{"text": "Method .The psychometric properties of the rating scales were evaluated based on data from the Study of Pharmacotherapy of Psychotic Depression .Results .The HAM - D 6 fulfilled the same criteria , whereas the full 17-item Hamilton Depression Scale failed to meet criteria for unidimensionality .", "label": "", "metadata": {}, "score": "28.29254"}
{"text": "Background .The Hamilton Depression Rating Scale ( HAM - D ) is commonly used as a screening instrument , as a continuous measure of change in depressive symptoms over time , and as a means to compare the relative efficacy of treatments .", "label": "", "metadata": {}, "score": "29.559809"}
{"text": "The primary outcome measure was the change from baseline in total score on Hamilton Rating Scale for Depression ( HAM - D ) .The Clinical Global Impression of Improvement ( CGI - I ) was rated at the endpoint .", "label": "", "metadata": {}, "score": "29.903479"}
{"text": "Table 2 .Clinical validity and responsiveness of the 17-item Hamilton Depression Rating Scale ( HAM - D 17 ) and the 6-item melancholia subscale ( HAM - D 6 ) .", "label": "", "metadata": {}, "score": "30.756868"}
{"text": "Table 3 .Analysis of psychometric validity / unidimensionality of the 17-item Hamilton Depression Rating Scale ( HAM - D 17 ) and the 6-item melancholia subscale ( HAM - D 6 ) .", "label": "", "metadata": {}, "score": "34.424355"}
{"text": "Discussion .This secondary analysis of the data from STOP - PD investigated psychometric aspects of PD with special focus on the HAM - D 17 , the HAM - D 6 , and seven constructed composite scales covering both depressive and psychotic symptoms .", "label": "", "metadata": {}, "score": "36.447197"}
{"text": "Baseline characteristics of subjects .Hamilton Depression Scale .Five studies provided mean baseline HAM - D scores .18 19 21 23 25 The patients in these studies had mean baseline HAM - D scores above 17 , showing that they were moderately to severely depressed .", "label": "", "metadata": {}, "score": "36.604935"}
{"text": "The self- and clinician - administered versions of the HAM - D 6 measure depressed mood , self - esteem and guilt , social interaction and interests , psychomotor retardation , anxiety , and somatic symptoms .", "label": "", "metadata": {}, "score": "37.093426"}
{"text": "Provenance and peer review Not commissioned ; externally peer reviewed .J Psychiatr Res 2004 ; 38 : 577 - 82 . . .Relative sensitivity of the Montgomery - Asberg depression rating scale , the Hamilton depression rating scale and the Clinical Global Impressions rating scale in antidepressant clinical trials : a replication analysis .", "label": "", "metadata": {}, "score": "38.65752"}
{"text": "Licht RW , Qvitzau S , Allerup P , et al .: Validation of the Bech - Rafaelsen Melnacholia Scale and the Hamilton Depression Scale in patients with major depression : Is the total score a valid measure of illness severity ?", "label": "", "metadata": {}, "score": "38.9345"}
{"text": "This HAM - D 6 is composed of items measuring core symptoms of depression ( i.e. , depressed mood , self - esteem and feelings of guilt , social interaction and interests , psychomotor retardation , anxiety , and somatic symptoms ) .", "label": "", "metadata": {}, "score": "39.05866"}
{"text": "Primary and secondary outcome measures GPRI , Hamilton Depression Rating Scale ( HAM - D ) , Hamilton Anxiety Rating Scale ( HAM - A ) , Brief Symptom Inventory ( BSI ) and Impact of Event Scale ( IES ) .", "label": "", "metadata": {}, "score": "39.55725"}
{"text": "PubMed View Article .CMAJ 2005 , 173 : 1327 - 1334 .PubMed View Article .Ballesteros J , Bobes J , Bulbena A , Luque A , Dal - R\u00e9 R , Ibarra N , G\u00fcemes I : Sensitivity to change , discriminative performance , and cutoff criteria to define remission for embedded short scales of the Hamilton Depression Rating Scale ( HAMD ) .", "label": "", "metadata": {}, "score": "39.655136"}
{"text": "Data extraction Remission , response and symptom improvement scores on the Hamilton Depression Scale , Montgomery - Asberg Depression Rating Scale and Clinical Global Impressions - Severity scales were extracted .", "label": "", "metadata": {}, "score": "39.78604"}
{"text": "The HAM - D25 is the 25-item version of a scale used to assess the range of depressive symptoms including depressed mood , work and activities , sleep , suicidal thinking , psychomotor agitation / retardation , appetite , sexual interest , anxiety , somatic symptoms , and cognitive symptoms .", "label": "", "metadata": {}, "score": "41.30016"}
{"text": "Validation of the Bech - Rafaelsen Melancholia Scale and the Hamilton Depression Scale in patients with major depression ; is the total score a valid measure of illness severity ?", "label": "", "metadata": {}, "score": "41.429707"}
{"text": "Figure 1 .The \" depression ruler \" .This figure illustrates how the six individual items from the melancholia subscale ( HAM - D6 ) of the Hamilton Depression Rating Scale relate to the severity of depression .", "label": "", "metadata": {}, "score": "41.575726"}
{"text": "As a screening measure , scores of 7 + suggest clinically significant depressive symptomatology [ 33 ] .Whereas the self - report HAM - D 6 is based solely on patient responses , the clinician - administered version integrates patients ' responses and clinical observation .", "label": "", "metadata": {}, "score": "41.920498"}
{"text": "Approximately 13.0 - 20.1 % of participants reached the threshold of moderate to severe distress , respectively , ( see table 2 ) .HAM - D and HAM - A interview data from 463 participants were used as a further validation tool to measure psychological symptoms postgenetic testing results .", "label": "", "metadata": {}, "score": "42.3111"}
{"text": "PubMed View Article .Faries D , Herrera J , Raymajhi J , DeBrota D , Demitrack M , Potter WZ : The responsiveness of the Hamilton Depression Rating Scale .", "label": "", "metadata": {}, "score": "42.369415"}
{"text": "PubMed View Article .Maier W , Philipp M : Improving the assessment of severity of depressive states : a reduction of the Hamilton Depression Scale .", "label": "", "metadata": {}, "score": "42.691013"}
{"text": "However , neither the clinical nor the psychometric validity of the HAM - D 17 has been established in relation to PD .In some trials , this problem has been addressed by including an additional dichotomous rating of the psychotic symptoms and making their absence part of the response / remission criteria [ 31 , 52 ] .", "label": "", "metadata": {}, "score": "42.764877"}
{"text": "PubMed View Article .Faries D , Herrera J , Rayamajhi J , DeBrota D , Demitrack M , Potter WZ : The responsiveness of the Hamilton Depression Rating Scale .", "label": "", "metadata": {}, "score": "42.839424"}
{"text": "Patients consumed 250 mg of pharmacy - grade hypericum extract or 75 mg imipramine twice daily for six weeks .Main outcome measures included the Hamilton depression rating scale , clinical global impression scale , and patient global impression scale .", "label": "", "metadata": {}, "score": "43.446976"}
{"text": "Confirmatory factor analytic models .Goodness of fit indices for both models were within optimal parameters [ 35 ] .For both patient and clinician versions , the HAM - D 6 appears to measure a unidimensional depression construct .", "label": "", "metadata": {}, "score": "43.853188"}
{"text": "PubMed View Article .Hamilton M : A rating scale for depression .J Neurosurg 1960 , 23 : 56 - 62 .Hamilton M : Development of a rating sale for primary depressive illness .", "label": "", "metadata": {}, "score": "44.183388"}
{"text": "Question 2 .The clinical validity of the HAM - D 17 and the HAM - D 6 in relation to PD was evaluated by Spearman 's correlation analysis of the HAM - D 17 /HAM - D 6 total scores vs. CGI - S scores at week 4 , 8 , and 12 .", "label": "", "metadata": {}, "score": "44.48166"}
{"text": "These findings suggest that a 7 + HAM - D 6 score is an effective threshold value .Most notably , responses by older adults , themselves , enable effective depression screening between euthymic patients and those reporting pronounced depressive symptomatology .", "label": "", "metadata": {}, "score": "44.830032"}
{"text": "PubMed View Article .Santor DA , Coyne JC : Examining symptoms expression as a function of symptom severity : item performance on the Hamilton Rating Scale for depression .", "label": "", "metadata": {}, "score": "44.830154"}
{"text": "To assess the sensitivity , specificity and predictive value of the GPRI , the follow - up HAM - D and HAM - A were used to identify ' cases ' who met cut - offs for either the depression or anxiety symptomatology .", "label": "", "metadata": {}, "score": "44.929867"}
{"text": "2 Are the HAM - D 17 and the HAM - D 6 clinically valid and responsive measures of the severity of psychotic depression ?The results of the correlation analyses assessing the clinical validity and the responsiveness of the HAM - D 17 and the HAM - D 6 indicated that both scales were able to capture both the severity of PD and the clinical improvement during treatment .", "label": "", "metadata": {}, "score": "45.04686"}
{"text": "Both self- and clinician - administered versions of the HAM - D 6 were next compared to assess the relative contribution of items to measurement ( invariance or equivalence analyses ) .", "label": "", "metadata": {}, "score": "45.275307"}
{"text": "PubMed View Article .Carmody TJ : The Montgomery - Asberg and the Hamilton ratings of depression : a comparison of measures .Eur Neuropsychopharmacol 2006 , 16 : 601 - 611 .", "label": "", "metadata": {}, "score": "45.33631"}
{"text": "Moreover , 100 % sensitivity ( and 91 % specificity ) was found between patient HAM - D 6 responses and clinician diagnoses of depression .", "label": "", "metadata": {}, "score": "45.427418"}
{"text": "Our results suggest that the HAMD - BPRS 11 is a more valid measure than pure depression scales for evaluating the severity of PD .Significant outcomes .", "label": "", "metadata": {}, "score": "45.47136"}
{"text": "Which items on the Brief Psychiatric Rating Scale ( BPRS ) correlate with the severity of delusions and hallucinations in psychotic depression ?Is a composite rating scale consisting of the HAM - D 6 plus BPRS items covering delusions / hallucinations a valid measure of the severity of psychotic depression ?", "label": "", "metadata": {}, "score": "45.601154"}
{"text": "These findings are in accord with previously reported findings [ 13 - 15 , 25 , 26 , 33 ] .Comparing clinician and patient HAM - D 6 responses indicate satisfactory correspondence between the two .", "label": "", "metadata": {}, "score": "46.102505"}
{"text": "The HAM - D 17 does , however , contain a subscale that fulfills the criteria of both clinical validity and unidimensionality and which does not mistake occurrence of adverse effects for improvement in depression .", "label": "", "metadata": {}, "score": "46.466057"}
{"text": "The HAM - D evaluates a depressed mood , as well as vegetative and cognitive symptoms of depression and comorbid anxiety symptoms .29 The HAM - A quantifies the severity of anxiety symptomatology and consists of 14 items .", "label": "", "metadata": {}, "score": "46.907944"}
{"text": "Rothschild AJ , Samson JA , Bond TC , Luciana MM , Schildkraut JJ , Schatzberg AF .Hypothalamic - pituitary - adrenal axis activity and 1-year outcome in depression .", "label": "", "metadata": {}, "score": "46.99771"}
{"text": "Is the factor structure of HAM - D 17 in psychotic depression similar to that of non - psychotic depression ?Are the HAM - D 17 and the HAM - D 6 clinically valid and responsive measures of the severity of psychotic depression ?", "label": "", "metadata": {}, "score": "47.12413"}
{"text": "Patient raters were blind to the pharmacological treatment of study participants .Secondary outcome measures included the Snaith - Hamilton Pleasure Scale ( SHAPS ) [ 18 ] to assess anhedonia and the Sheehan Disability Scale ( SDS ) to assess disability : both scales were collected at baseline and endpoint .", "label": "", "metadata": {}, "score": "47.328003"}
{"text": "Second , we wished to assess whether a rating scale covering both psychotic and depressive symptoms could be a valid measure of the severity of psychotic depression .", "label": "", "metadata": {}, "score": "47.421234"}
{"text": "The authors of a recent study with older adults that compared six depression scales concluded that the HAM - D 6 was the only one to demonstrate total scalability , and that it had the greatest external validity [ 18 ] .", "label": "", "metadata": {}, "score": "47.47616"}
{"text": "As previously mentioned , Bech et al .[ 33 ] suggest that a HAM - D 6 score of 7 + is suggestive of clinically significant depressive symptoms ( i.e. , warranting thorough clinical assessment ) .", "label": "", "metadata": {}, "score": "47.567326"}
{"text": "The clinical utility and predictive value of the GPRI was supported as well .A GPRI score above the cut - off of 50 at baseline was able to predict 84 % of ' distress ' cases identified by HAM - D or HAM - A , a strong indicator of its potential usefulness in a clinical setting .", "label": "", "metadata": {}, "score": "47.65163"}
{"text": "Entsuah R , Shaffer M , Zhang J : A critical examination of the sensitivity of unidimensional scales derived from the Hamilton Depression Rating Scale of antidepressant drug effects .", "label": "", "metadata": {}, "score": "47.870167"}
{"text": "View Article .Gibbons RD , Clark DC , Kupfer DJ : Exactly what does the Hamilton Depression Rating Scale measure ?J Psychiatr Res 1993 , 27 : 259 - 273 .", "label": "", "metadata": {}, "score": "48.080467"}
{"text": "Furthermore , the intra - class correlations for 5 of the 6 items were found to be above 0.60 .This congruence between patients and clinicians for most scale items implies that patients ' responses can be trusted and accepted as a valid evaluation of depression .", "label": "", "metadata": {}, "score": "48.538387"}
{"text": "Our analysis identified nine BPRS items , which correlated significantly with at least one of the two SADS items of delusions and hallucinations .These items were used to construct a total of seven composite rating scales , which were then tested for clinical validity , psychometric validity , and responsiveness .", "label": "", "metadata": {}, "score": "48.675774"}
{"text": "Bech P , Boyer P , Germain JM et al .HAM - D17 and HAM - D6 sensitivity to change in relation to desvenlafaxine dose and baseline depression severity in major depressive disorder .", "label": "", "metadata": {}, "score": "48.903717"}
{"text": "PubMed View Article .Bech P , Allerup P , Gram LFN , Rosenberg R , Jacobsen O , Nagy A : The Hamilton Depression Scale : evaluation of objectivity using logistic models .", "label": "", "metadata": {}, "score": "48.925667"}
{"text": "However , in the present analysis , psychic anxiety did not group among the other items from the HAM - D 6 .On the other hand , the item of somatic anxiety had a loading similar to that of the core items of depression .", "label": "", "metadata": {}, "score": "48.983345"}
{"text": "1 , 2 Studies utilising standardised measures of distress ( eg , global measures of anxiety or depression symptoms ) have demonstrated that 8 - 25 % of individuals undergoing genetic testing experience distress , the level of which falls within the clinical ranges for depression and anxiety .", "label": "", "metadata": {}, "score": "49.00066"}
{"text": "Bech P .The three - fold Hamilton Depression Scale : an editorial comment to Isacsson G , Adler M. Randomized clinical trials underestimate the efficacy of antidepressants in less severe depression ( 1 ) .", "label": "", "metadata": {}, "score": "49.37979"}
{"text": "Cubells JF , Price LH , Meyers BS et al .Genotype - controlled analysis of plasma dopamine beta - hydroxylase activity in psychotic unipolar major depression .", "label": "", "metadata": {}, "score": "49.722412"}
{"text": "This is consistent with invariance analyses reported above , see Table 2 .Table 2 .Intra - class correlation coefficients between older patient and clinician HAM - D 6 responses .", "label": "", "metadata": {}, "score": "49.898476"}
{"text": "Data on the characteristics of study participants were entered into a table , recording the age and sex of participants , sample sizes in the citalopram and placebo treatment groups , medication doses , drop - out rates and treatment duration .", "label": "", "metadata": {}, "score": "49.95736"}
{"text": "HAM - D 6 + hallucinatory behavior + unusual thought content + suspiciousness + emotional withdrawal + blunted affect + somatic concern + uncooperativeness .These composite scales were subsequently tested for clinical validity , psychometric unidimensionality , and responsiveness using the methods described above ( Question 2 + 3 ) .", "label": "", "metadata": {}, "score": "50.04719"}
{"text": "The validity of the HAMD - BPRS 11 has not been confirmed in independent samples .Introduction .This distinction between PD and non - psychotic depression ( non - PD ) will not be changed in the upcoming DSM-5 , and there have been no reports suggesting that this should be the case for the ICD-11 [ 3 ] .", "label": "", "metadata": {}, "score": "50.077164"}
{"text": "Throughout the study , HAM - D 17 ratings were performed by trained research assistants , whereas the DAS , SADS , CGI - S , CGI - I , and the BPRS were administered by psychiatrists who were not blinded to the HAM - D 17 scores [ 31 ] .", "label": "", "metadata": {}, "score": "50.091072"}
{"text": "The goal of this study was to assess the psychometric properties of self - report vs. clinician versions on the Hebrew HAM - D 6 .", "label": "", "metadata": {}, "score": "50.403004"}
{"text": "In such a study , the HAM - D 17 /BPRS ratings and the CGI ratings respectively should be performed by independent teams of raters .", "label": "", "metadata": {}, "score": "50.62123"}
{"text": "Table 4 .Correlation between Brief Psychiatric Rating Scale ( BPRS ) item scores and Schedule of Affective Disorders and Schizophrenia ( SADS ) delusions / hallucinations scores .", "label": "", "metadata": {}, "score": "50.88948"}
{"text": "Using a GPRI cut - off score of 50 , the instrument was able to predict 84 % of the ' cases ' identified by HAM - D or HAM - A conducted postgenetic testing results , with a specificity value of 60 % ( figure 1 ) .", "label": "", "metadata": {}, "score": "51.02998"}
{"text": "However , self - reported CGI - ratings correlated significantly with BDI and the validity of BDI as an instrument for the assessment of depression severity has been shown in numerous studies [ for some recent examples see e.g. , [ 27 , 28 ] ] .", "label": "", "metadata": {}, "score": "51.197365"}
{"text": "Primary outcome measure was the HAM - D total score .The Clinical Global Impression of Improvement ( CGI - I ) [17 ] was rated at endpoint .", "label": "", "metadata": {}, "score": "51.296703"}
{"text": "All studies , except for those of Frank et al 20 and Montgomery et al 24 provided mean baseline CGI - S scores .Average baseline scores in these study populations were above 4 , indicating a moderate level of illness severity .", "label": "", "metadata": {}, "score": "51.364403"}
{"text": "2 , 7 , 12 These findings highlight the importance of considering risk factors in addition to the type of the test result itself .Individuals who have elevated psychological symptoms at the pretest stage and those with a previous psychiatric history ( ie , depression ) are particularly at risk for an adverse psychological outcome after testing .", "label": "", "metadata": {}, "score": "51.413643"}
{"text": "The evaluation of the psychometric unidimensionality of the HAM - D 17 and the HAM - D 6 in relation to PD was performed by Mokken analysis [ 64 ] .", "label": "", "metadata": {}, "score": "51.437897"}
{"text": "In the STOP - PD , the CGI and BPRS ratings were indeed performed by psychiatrists , whereas the HAM - D 17 ratings were conducted by trained research assistants with documented reliability [ 31 ] .", "label": "", "metadata": {}, "score": "51.503654"}
{"text": "However , when interpreted in the light of the only clinical validation of the HAM - D 17 performed to date ( 42 ) , where the six items from the HAM - D 6 were identified as those carrying actual information on depressive severity , it makes perfect sense .", "label": "", "metadata": {}, "score": "51.768776"}
{"text": "A total of 63 ' cases ' ( 13.6 % of the 463 completers ) were identified as having psychological distress levels above the specified thresholds defined in the methods section for either anxiety or depression symptoms or both .", "label": "", "metadata": {}, "score": "51.844036"}
{"text": "Where there was a discrepancy , 14 patients provided HAM - D 6 responses in clinical range , while the SCID diagnoses indicated no major depressive episode .", "label": "", "metadata": {}, "score": "51.88607"}
{"text": "HAMD - BPRS 12 .HAMD - BPRS 13 .The Spearman 's coefficients reflecting clinical validity were above 0.74 for all composite rating scales for week 4 , 8 , and 12 .", "label": "", "metadata": {}, "score": "52.144753"}
{"text": "However , among the STOP - PD participants , scores on the emotional withdrawal and blunted affect ( common features of depression ) but not conceptual disorganization ( a more typical feature of schizophrenia ) items correlated with the SADS items of delusions and hallucinations .", "label": "", "metadata": {}, "score": "52.55471"}
{"text": "This would be confirmed by a high HAM - D or HAM - A score or ' case ' during 1-month follow - up .", "label": "", "metadata": {}, "score": "52.66468"}
{"text": "The construct validity was supported by high correlations between GPRI and BSI and IES .The predictive value was demonstrated by a receiver operating characteristic curve of 0.78 plotting GPRI against follow - up assessments using HAM - D and HAM - A. Conclusions With a cut - off score of 50 , GPRI identified 84 % of participants who displayed distress postgenetic testing results , supporting its potential usefulness in a clinical setting .", "label": "", "metadata": {}, "score": "52.706837"}
{"text": "I recorded baseline measures of symptom severity and the treatment setting for each study .I tabulated the proportions of patients who achieved response or remission in the citalopram and placebo arms of selected studies .", "label": "", "metadata": {}, "score": "52.713684"}
{"text": "The Mokken analysis was performed using the dedicated MSP program [ 66 ] .Question 4 .Question 5 .Based on the answers of Question 1 - 4 , we constructed a number of composite rating scales covering both depressive and psychotic symptoms .", "label": "", "metadata": {}, "score": "52.745125"}
{"text": "Both contributed to measurement of depression as reported by patients to a greater degree than that reported by the clinicians .See Table 1 .Table 1 .", "label": "", "metadata": {}, "score": "52.793003"}
{"text": "The Mokken analysis was based on HAM - D 17 ratings from week 4 to have sufficient variance in the total scores .The rating on item 13 ( general somatic ) was multiplied by 2 to obtain a score range of 0 - 4 on all HAM - D 6 items .", "label": "", "metadata": {}, "score": "52.882084"}
{"text": "Outcomes .Remission .Two of the eight studies reported remission rates .This evaluation was based on observed cases only , and no comparable data for the placebo group were provided .", "label": "", "metadata": {}, "score": "53.01451"}
{"text": "Most studies omitted data on the remission rates , and none of the studies reported a full set of outcome variables in a way that can be incorporated in a meta - analysis .", "label": "", "metadata": {}, "score": "53.07541"}
{"text": "Selective reporting of outcome data was evident in all studies , as easily extractable summary statistics such as remission and response rates were often omitted from publication , or data were presented in a form that could not be incorporated into a meta - analysis .", "label": "", "metadata": {}, "score": "53.201538"}
{"text": "BSI : The BSI is a 53-item measure of psychological distress that contains three global scales ( 1 ) depression , ( 2 ) anxiety and ( 3 ) somatisation .", "label": "", "metadata": {}, "score": "53.213326"}
{"text": "Posener JA , Debattista C , Williams GH , Chmura Kraemer H , Kalehzan BM , Schatzberg AF .24-Hour monitoring of cortisol and corticotropin secretion in psychotic and nonpsychotic major depression .", "label": "", "metadata": {}, "score": "53.233753"}
{"text": "J. C. Ballenger , \" Clinical guidelines for establishing remission in patients with depression and anxiety , \" Journal of Clinical Psychiatry , vol .60 , pp .", "label": "", "metadata": {}, "score": "53.2577"}
{"text": "Question 2 .The results of the correlation analyses investigating the clinical validity and responsiveness of the HAM - D 17 and the HAM - D 6 are shown in Table 2 .", "label": "", "metadata": {}, "score": "53.340332"}
{"text": "Rothschild AJ , Williamson DJ , Tohen MF et al .A double - blind , randomized study of olanzapine and olanzapine / fluoxetine combination for major depression with psychotic features .", "label": "", "metadata": {}, "score": "53.420258"}
{"text": "Results .Reponses to the HAM - D 6 suggest that this instrument measures a unidimensional construct with each of the scales ' six items contributing significantly to the measurement .", "label": "", "metadata": {}, "score": "53.48089"}
{"text": "The risk factors for psychological symptoms among individuals undergoing genetic testing have been delineated in several studies .4 , 8 , 9 While there is generally elevated distress in using global measures for depression or anxiety among those who receive positive test results , 9 - 11 individuals testing negative or receiving uninformative results may also have adjustment difficulties 12 following testing .", "label": "", "metadata": {}, "score": "53.551846"}
{"text": "This result indicates that the improvement in the HAM - D scores of subjects treated with citalopram was 0.27 standard deviations better than the improvement in those treated with placebo .", "label": "", "metadata": {}, "score": "53.829796"}
{"text": "Furthermore , patients were not eligible for the study if they were taking other psychoactive medications or had received electroconvulsive therapy within the 6 months before the initial assessment .", "label": "", "metadata": {}, "score": "54.595573"}
{"text": "[ 44 ] ) .HAM - D 17 .HAM - D 6 .Question 4 .The results of the correlation between ratings on the individual BPRS items vs. the SADS delusion and hallucination ratings at baseline are shown in Table 4 .", "label": "", "metadata": {}, "score": "54.63162"}
{"text": "Among patients who completed the study , the response rates were as high as 62.5 % .Full remission , in which depressed patients are essentially indistinguishable from healthy subjects , was achieved by 37.5 % of completers .", "label": "", "metadata": {}, "score": "54.65068"}
{"text": "All three factors met the minimum eigenvalue criteria of 1 .Example items included : ' My worries about the disease affect my daily mood ' ; ' The disease for which I am at risk is currently causing a significant disruption in my family life ' .", "label": "", "metadata": {}, "score": "54.8813"}
{"text": "The threshold for unidimensionality is generally considered to be 0.40 [ 64 ] .Consequently , as in the case of non - PD , the HAM - D 6 and not the HAM - D 17 appeared to be a sufficient statistic , that is , the total score is a valid measure for the severity of PD .", "label": "", "metadata": {}, "score": "55.203926"}
{"text": "According to the results of our analyses of the seven composite rating scales , we believe that the HAMD - BPRS 11 displays the ideal balance between psychometric unidimensionality , content validity , clinical validity , and responsiveness .", "label": "", "metadata": {}, "score": "55.225258"}
{"text": "These differences have been documented for potential precipitating factors [ 5 - 7 ] , underlying biology [ 8 - 11 ] , symptomatology beyond the psychotic symptoms [ 12 , 13 ] , long - term prognosis [ 14 - 19 ] , and responsiveness to psychopharmacological treatment and electroconvulsive therapy [ 20 - 30 ] .", "label": "", "metadata": {}, "score": "55.344055"}
{"text": "Clinical depression is common in primary care with rates of prevalence among older adults ranging between 4 - 24 % [ 5 , 6 ] .", "label": "", "metadata": {}, "score": "55.500854"}
{"text": "Beyond that , in a recent meta - analysis , Hedges et al .[ 11 ] calculated effect sizes for CGI and other rating scales from 16 different studies on social phobia and found mostly comparable effect sizes for the CGI - I and several social anxiety scales .", "label": "", "metadata": {}, "score": "55.690636"}
{"text": "In all analyses of the seven composite scales , the rating on Hamilton item 13 ( general somatic ) was multiplied by 2 . Results .", "label": "", "metadata": {}, "score": "55.985435"}
{"text": "( 3 )During this phase , specific therapeutic exercises are carried out .These include standard elements of cognitive behavioural therapy for depression .( 4 )", "label": "", "metadata": {}, "score": "56.16488"}
{"text": "Above , only patients suffering from a MDD have been assessed which impedes generalizability of the reported results to other patient groups .Because the length of the current depressive episode could not be determined from study data , it could not be ruled out that length of depressive episode or chronicity could have had an influence on results .", "label": "", "metadata": {}, "score": "56.423462"}
{"text": "Stochl J , Jones PB , Croudace TJ .Mokken scale analysis of mental health and well - being questionnaire item responses : a non - parametric IRT method in empirical research for applied health researchers .", "label": "", "metadata": {}, "score": "56.437912"}
{"text": "I examined the abstracts of all identified studies , selecting randomised double - blind studies of citalopram in patients with major depressive disorder .Reference lists of review articles and other studies of citalopram were also searched for publications satisfying the inclusion criteria .", "label": "", "metadata": {}, "score": "56.438293"}
{"text": "These limitations have led researchers to propose abridged versions of the HAM - D that are quick to administer yet sensitive to measurement of symptom levels , change over time and relative differences in treatment efficacy .", "label": "", "metadata": {}, "score": "56.602425"}
{"text": "In clinical studies of PD , choosing a rating scale is particularly challenging due to the clinical significance of both the psychotic and the depressive domains of the syndrome [ 4 ] .", "label": "", "metadata": {}, "score": "56.66248"}
{"text": "Studies of MDD that focused on relapse prevention , treatment augmentation or treatment - resistant cases were also excluded , as these studies would have introduced additional heterogeneity into this evaluation .", "label": "", "metadata": {}, "score": "56.668198"}
{"text": "Targum et al .[19 ] found significantly augmented scoring variance due to treatment emergent symptoms and developed targeted scoring criteria for the CGI to enhance inter - rater reliability .", "label": "", "metadata": {}, "score": "57.038094"}
{"text": "For an individual who reports a history of psychological illness , a mental health professional could further assess current psychological functioning and implement specific approaches , as well as offering cognitive - behavioural strategies or psychotropic medication to assist in the management of anxiety or depressive symptoms .", "label": "", "metadata": {}, "score": "57.124794"}
{"text": "For example , the CGI , especially the CGI improvement scale ( CGI - I ) has been widely utilized as an efficacy measure in clinical drug trials in different mental disorders [ e.g. , depression , schizophrenia ; [ 2 , 3 ] ] .", "label": "", "metadata": {}, "score": "57.183006"}
{"text": "The incidence of spontaneously reported or observed adverse events was reported at every follow - up visit and patients were excluded from the study if side effects were considered as intolerable .", "label": "", "metadata": {}, "score": "57.244896"}
{"text": "At 8 weeks , a significant decrease in HAM - D score was observed with response achieved by 60 % of the patients and remission by 36 % .", "label": "", "metadata": {}, "score": "57.27881"}
{"text": "The patient who dropped out was classified as nonresponder .The 9 patients who achieved remission from depression came from the group of 15 patients who met criteria of responders .", "label": "", "metadata": {}, "score": "57.31485"}
{"text": "Nevertheless , a rating scale that captures both the depressive and psychotic dimensions of PD is not available .Aims of the study .The present study addressed the apparent lack of evaluation of the rating scales used in psychotic depression .", "label": "", "metadata": {}, "score": "57.546616"}
{"text": "Meyers BS , Flint AJ , Rothschild AJ et al .A double - blind randomized controlled trial of olanzapine plus sertraline vs olanzapine plus placebo for psychotic depression : the study of pharmacotherapy of psychotic depression ( STOP - PD ) .", "label": "", "metadata": {}, "score": "57.595467"}
{"text": "These three final items had low item total correlation because they were different from the rest of the items in that they focused on direct experiences related to the illness , rather than psychosocial - related items .", "label": "", "metadata": {}, "score": "57.75431"}
{"text": "Note .Intra - class correlation coefficients .Intra - class correlation coefficients ( ICC ) were next computed to directly compare HAM - D 6 ratings for patient - clinician pairings ( i.e. , patient self - report vs. corresponding clinician ratings for that patient ) .", "label": "", "metadata": {}, "score": "57.75834"}
{"text": "Wijkstra J , Burger H , van den Broek WW et al .Treatment of unipolar psychotic depression : a randomized , double - blind study comparing imipramine , venlafaxine , and venlafaxine plus quetiapine .", "label": "", "metadata": {}, "score": "57.839714"}
{"text": "The results are summarized in Table 1 and demonstrate that there were significant changes from baseline for secondary efficacy variables such as SHAPS and SDS ( for both scales .", "label": "", "metadata": {}, "score": "57.8463"}
{"text": "However , there is a growing body of literature suggesting that this scale suffers from important weaknesses as a quantitative measure of depression .First and foremost , it displays poor clinical validity , as the total score does not always reflect the global severity of depressive states as perceived by experienced psychiatrists [ 42 ] .", "label": "", "metadata": {}, "score": "58.085014"}
{"text": "There is a lack of consensus on how to measure the severity of PD and the majority of treatment studies only considers improvement in depression and do not take change in psychotic symptoms into account in their definitions of remission or response [ 4 , 67 ] .", "label": "", "metadata": {}, "score": "58.11371"}
{"text": "This assertion is supported by meta - analytic study findings indicating that certain scale items are less sensitive to measurement of symptom severity .In addition , some items have comparatively poor inter - rater and retest reliability , and the response - option format may not be optimal [ 17 ] .", "label": "", "metadata": {}, "score": "58.16223"}
{"text": "Each item consists of four self - referring statements ( e.g. \" I am sad \" ) .Item scores range from 0 to 3 and participants are supposed to choose one or more statements per item that represents best their mental state during the last week .", "label": "", "metadata": {}, "score": "58.170727"}
{"text": "These results were confirmed by significantly improvements seen in all the secondary outcome measures .The percentage of responders throughout the study was rather high .", "label": "", "metadata": {}, "score": "58.309254"}
{"text": "Statistical Analysis .An intent - to - treat analysis was utilized with the last available evaluation carried forward as endpoint ( last observation carried forward , LOCF ) .", "label": "", "metadata": {}, "score": "58.34072"}
{"text": "Risk factors for psychological distress identified by the literature review provided the basis for item generation .Items were written in a mixed format where respondents were asked for their endorsement of each statement ranging from a Yes / No for risk factors of binary nature , to a 5-point Likert - type scale for risk factors with stages in frequency and/or intensity .", "label": "", "metadata": {}, "score": "58.473732"}
{"text": "PubMed View Article .Bech P , Gram LF , Dein E , Jacobson O , Vitger J , Bolwing TG : Quantitative rating of depressive states .", "label": "", "metadata": {}, "score": "58.50601"}
{"text": "Selection criteria .I selected published , randomised , double - blind studies comparing citalopram with placebo among adult participants over the age of 18 , who were diagnosed as having MDD using DSM - III , 6 DSM - IIIR , 7 DSM - IV 8 ICD-9 9 or ICD-10 .", "label": "", "metadata": {}, "score": "58.57721"}
{"text": "MADRS measures the overall severity of depressive symptoms .The MADRS had a 10-item checklist .Items are rated on a scale of 0 - 6 , for a total numeric range of scores from 0 ( depressive symptoms absent ) to 60 ( numerically highest level of depressive symptoms ) .", "label": "", "metadata": {}, "score": "58.709236"}
{"text": "MADRS measures the overall severity of depressive symptoms .The MADRS had a 10-item checklist .Items are rated on a scale of 0 - 6 , for a total numeric range of scores from 0 ( depressive symptoms absent ) to 60 ( numerically highest level of depressive symptoms ) .", "label": "", "metadata": {}, "score": "58.709236"}
{"text": "Background .Depression is a common debilitative psychiatric condition ranked high in prevalence among all mental health conditions [ 1 ] .Lifetime prevalence may be as high as 20 % [ 2 ] and , at any one time , 5 - 10 % of the world 's population meets diagnostic criteria for a major depressive episode [ 3 ] .", "label": "", "metadata": {}, "score": "58.8927"}
{"text": "We included cases to be identified by either anxiety and/or depressive symptomatology as both have been reported in the literature .This step assesses if there was systematic bias resulting from the loss of information in the follow - up period .", "label": "", "metadata": {}, "score": "59.199398"}
{"text": "We attempted to obtain a larger sample of individuals undergoing genetic testing for HD or Lynch Syndrome , which would presumably provide a greater sample of males .", "label": "", "metadata": {}, "score": "59.33863"}
{"text": "Keywords : .Abstract .Objective .Psychotic depression ( PD ) is a highly debilitating condition , which needs intensive monitoring .However , there is no established rating scale for evaluating the severity of PD .", "label": "", "metadata": {}, "score": "59.39004"}
{"text": "Importantly , Turner revised the estimation of citalopram 's effectiveness to 0.01 after including unpublished results .My conclusions regarding the effect of citalopram on the response and symptom improvement in MDD are consistent with the earlier reviews of this drug . 1 48 - 50 Those reviews , however , have not examined the risk of bias in published studies , or the effect of citalopram on remission of MDD .", "label": "", "metadata": {}, "score": "59.42669"}
{"text": "Simultaneously , patients ' ratings correlated most strongly with BDI dif for both CGI - I and CGI - S dif while correlations with BDI for the other two perspectives were virtually zero .", "label": "", "metadata": {}, "score": "59.706398"}
{"text": "It is unclear whether the improvement index CGI - I or a difference score of the severity index CGI - S dif is more valid in depicting clinical change .", "label": "", "metadata": {}, "score": "59.727245"}
{"text": "For those who received a genetic test result , questionnaires were mailed within 2 weeks to 1 month of the disclosure of the test result .", "label": "", "metadata": {}, "score": "59.733246"}
{"text": "For both items , patients ' responses contributed more to the measurement of depression than clinicians ' responses .Furthermore , the intra - correlation coefficient for the psychomotor retardation was found to be very low , but for the social interaction and interests item , an adequate correlation emerged .", "label": "", "metadata": {}, "score": "59.740826"}
{"text": "Ostergaard SD , Bertelsen A , Nielsen J , Mors O , Petrides G .The association between psychotic mania , psychotic depression and mixed affective episodes among 14,529 patients with bipolar disorder .", "label": "", "metadata": {}, "score": "59.98287"}
{"text": "Among the abridged versions of the Hamilton scale , the most frequently used was developed by Bech et al .( HAM - D 6 ) [ 25 ] .", "label": "", "metadata": {}, "score": "60.01745"}
{"text": "All analyses were conducted using SPSS 17 for Windows .Results .CGI - I vs. CGI - S dif .On average , patients , therapists and teams rated the patient 's condition on CGI - I with a \" 2 \" indicating \" much improvement \" [ 1 ] ( see table \u200b table2 ) .", "label": "", "metadata": {}, "score": "60.0252"}
{"text": "Study selection Randomised , double - blind , placebo - controlled studies of citalopram in adults with MDD were included .Studies with medically ill or treatment resistant subjects were excluded , as were studies of relapse prevention .", "label": "", "metadata": {}, "score": "60.062737"}
{"text": "Any history or complication of schizophrenia or bipolar disorder .Any complication of body dysmorphic disorder .Substance dependence , as defined by DSM - IV - TR criteria , within 24 weeks of the Baseline visit .", "label": "", "metadata": {}, "score": "60.161644"}
{"text": "These studies have shown fairly consistently that PD responds better to the combination of an antipsychotic and an antidepressant than to monotherapy with either class of drugs [ 34 , 35 ] .", "label": "", "metadata": {}, "score": "60.18604"}
{"text": "Change on the LSAS Anxiety and Avoidance Subscales [ Time Frame : Baseline to Week 12 ] [ Designated as safety issue : No ] .", "label": "", "metadata": {}, "score": "60.285038"}
{"text": "Change on the LSAS Anxiety and Avoidance Subscales [ Time Frame : Baseline to Week 12 ] [ Designated as safety issue : No ] .", "label": "", "metadata": {}, "score": "60.285038"}
{"text": "Clinical Global Impression of Improvement Scale ( CGI - I ) [ Time Frame : Baseline to Week 12 ] [ Designated as safety issue : No ] .", "label": "", "metadata": {}, "score": "60.384586"}
{"text": "Clinical Global Impression Scale ( CGI ) .The CGI consists of three global measures .The CGI severity of illness measure ( CGI - S ) is rated from 1 ( normal , not at all ill ) to 7 ( among the most extremely ill patients ) .", "label": "", "metadata": {}, "score": "60.41503"}
{"text": "100 - 102 .Busner J , Targum SD , Miller DS .The Clinical Global Impressions scale : errors in understanding and use .Compr Psychiatry .", "label": "", "metadata": {}, "score": "60.512115"}
{"text": "The scale appeared highly acceptable to patients .A high face validity will contribute to better scale uptake being perceived as ' user friendly ' and clinically relevant , compared , for example , with a standardised psychological instrument on depression , which has demonstrated some barriers to clinic uptake .", "label": "", "metadata": {}, "score": "60.601242"}
{"text": "Nonetheless , in the light of our results , the Hebrew HAM - D 6 can be used to measure and screen depressive symptoms among elderly persons .", "label": "", "metadata": {}, "score": "60.616913"}
{"text": "Of the 47 patients enrolled in the study , 25 were administered fluoxetine and 22 were given placebo .Results : Subjects who received fluoxetine began to show significantly more improvement than patients who received placebo on both self- and observer - rated scales by the end of the first week of treatment .", "label": "", "metadata": {}, "score": "60.64028"}
{"text": "HAM - D 17 .HAM - D 6 .Question 3 .The Loevinger 's coefficients of homogeneity obtained by the Mokken analysis are shown in Table 3 alongside results from two treatment studies using the HAM - D 17 as primary outcome measure among patients with non - PD [ 44 , 45 ] .", "label": "", "metadata": {}, "score": "60.85881"}
{"text": "There were no concerns regarding subject safety .Patients must have a primary current diagnosis of MDD without psychotic features .Patients must be receiving ongoing antidepressant therapy at the time of screening .", "label": "", "metadata": {}, "score": "60.92381"}
{"text": "These results indicate that the Hebrew HAM - D 6 can be used to measure and screen for depressive symptoms among elderly patients .Keywords .", "label": "", "metadata": {}, "score": "61.191284"}
{"text": "British Medical Journal , Sept. 2 , 2000:321 , pp536 - 39 .Abstract .Objective To assess the effectiveness of citalopram for major depressive disorder ( MDD ) in adults , in a systematic review of all published , randomised , double - blind studies comparing it with a placebo .", "label": "", "metadata": {}, "score": "61.231705"}
{"text": "Moreover , the percentage of dropouts was very low for an 8-week study and only one male patient ( 4 % ) discontinued the trial after 4 weeks of treatment , not as a consequence of intolerable side effects , but due to obtaining new employment that required relocation .", "label": "", "metadata": {}, "score": "61.262787"}
{"text": "Typical cases display severe anhedonia , loss of interest , psychomotor retardation , and are tormented by hallucinations / delusions with typical themes of worthlessness , guilt , disease , or impending disaster [ 4 ] .", "label": "", "metadata": {}, "score": "61.515724"}
{"text": "Schizophr Res .doi : 10.1016/S0920 - 9964(02)00335 - 3 .[PubMed ] [ Cross Ref ] .Leon AC , Shear MK , Klerman GL , Portera L , Rosenbaum JF , Goldenberg I. A comparison of symptom determinants of patient and clinician global ratings in patients with panic disorder and depression .", "label": "", "metadata": {}, "score": "61.582832"}
{"text": "3 - 5 The emphasis on remission when evaluating effectiveness can be contrasted with earlier reviews of citalopram , focusing on symptom improvement or response as the main measure of outcome .", "label": "", "metadata": {}, "score": "61.6615"}
{"text": "The term ' placebos ' was used as a MeSH heading in the Medline , Cochrane and EMBASE database searches , and ' major depression ' was used as a MeSH heading in the PsychINFO search .", "label": "", "metadata": {}, "score": "61.733475"}
{"text": "View Article .Bagby RM , Ryder AG , Schuller DR , Marshall MB : The Hamilton Depression Rating Scale : Has the gold standard become a lead weight ?", "label": "", "metadata": {}, "score": "61.74533"}
{"text": "Unlike current psychological instruments used mainly in research studies in genetics clinics to identify existing global symptoms of depression and anxiety , or impacts , the GPRI assesses psychological risk factors , such as the specific anticipated impacts of a genetic testing result and the perception of the disease .", "label": "", "metadata": {}, "score": "61.788246"}
{"text": "Data analysis .Risk of bias was evaluated in accordance with the Cochrane Handbook for Systematic Reviews of Interventions , 17 using the following parameters : adequacy of sequence generation ; allocation concealment ; blinding of participants , personnel and outcome assessors ; incomplete outcome data ; and selective outcome reporting .", "label": "", "metadata": {}, "score": "61.796356"}
{"text": "Comparisons between SCID diagnoses of a major depressive episode and the patient HAM - D 6 responses were made to estimate sensitivity and specificity of the scale .", "label": "", "metadata": {}, "score": "61.912117"}
{"text": "Article summary .Article focus .Systematic review and meta - analysis of published randomised double - blind studies comparing citalopram with placebo in adults with major depressive disorder ( MDD ) .", "label": "", "metadata": {}, "score": "61.94742"}
{"text": "Response rates and change from baseline scores for citalopram , relative to placebo , were statistically significant in these meta - analyses , each one based on a subset of five studies .", "label": "", "metadata": {}, "score": "61.954567"}
{"text": "Research to date suggests that both versions are sensitive to change over time and can identify patients in remission [ 21 , 22 ] .Recently , a scale consisting of 7 items was also suggested [ 23 ] .", "label": "", "metadata": {}, "score": "61.9604"}
{"text": "However , to the best of our knowledge , the psychometric properties of responses to the Hebrew HAM - D 6 had yet to be examined .", "label": "", "metadata": {}, "score": "61.99687"}
{"text": "It is clear that there is not just one predominant factor , but rather a series of variables that can be assessed prior to receiving a test result that may contribute to elevated levels of psychological distress following genetic testing . 2 , 17 Emotional reactions may impede the assimilation of risk information and the adoption of preventive measures recommended following notification of a mutation .", "label": "", "metadata": {}, "score": "62.10384"}
{"text": "N ote : Maximum likelihood estimates ( standardize solution and significance levels ) .Significance estimates can not be computed for these two items .Clinician 6-Item HAM - D responses .", "label": "", "metadata": {}, "score": "62.177086"}
{"text": "In psychiatry , where laboratory tests reflecting illness severity are not available , systematic clinical assessment must be the basis for outcome measures , as emphasized in the discipline of ' clinimetrics ' [ 36 , 37 ] .", "label": "", "metadata": {}, "score": "62.192562"}
{"text": "The 1-month follow - up time point was selected as it is when elevated distress might occur .34 In addition , the 2-week duration criterion for depression defined by the Diagnostic and Statistical Manual of Mental Disorders , Fourth Edition is met by this time frame .", "label": "", "metadata": {}, "score": "62.261074"}
{"text": "PubMed View Article .Van Marwijk H , Hoeksema HIL , Hermas J , Kaptein AA , Mulder JD : Prevalence of depressive symptoms and depressive disorder in primary care patients over 65 years of age .", "label": "", "metadata": {}, "score": "62.28732"}
{"text": "PubMed View Article .Bech P , Cialdella P , Haugh MC , et al .: Meta - analysis of randomized controlled trials of fluoxetine v. placebo and tricyclic anidepressants in the short - term treatment of major depression .", "label": "", "metadata": {}, "score": "62.31233"}
{"text": "PubMed View Article .Cuijpers F , Smith P : Excess mortality in depression : a meta - analysis of community studies .J Affect Disord 2002 , 72 : 36 - 227 .", "label": "", "metadata": {}, "score": "62.477238"}
{"text": "One study 20 had only 16 participants .All patients recruited in these studies were diagnosed as having MDD using the criteria in the Diagnostic and Statistical Manual of Mental Disorders III , III - R or IV .", "label": "", "metadata": {}, "score": "62.491714"}
{"text": "Leadholm AK , Rothschild AJ , Nolen WA , Bech P , Munk - Jorgensen P , Ostergaard SD .The treatment of psychotic depression : is there consensus among guidelines and psychiatrists ?", "label": "", "metadata": {}, "score": "62.504066"}
{"text": "Alternatively , genetic clinics with available psychosocial personnel could utilise the tool to guide referrals for a formal psychosocial assessment that can further explore and address specific , self - reported psychological factors .", "label": "", "metadata": {}, "score": "62.536636"}
{"text": "I examined the quality of published studies and the risk of bias , setting remission of MDD as the primary measure of effectiveness in this review .", "label": "", "metadata": {}, "score": "62.658287"}
{"text": "doi : 10.1186/1744 - 859X-8 - 4 .[ PMC free article ] [ PubMed ] [ Cross Ref ] .Kadouri A , Corruble E , Falissard B. The improved Clinical Global Impression Scale ( iCGI ) : development and validation in depression .", "label": "", "metadata": {}, "score": "62.71981"}
{"text": "PubMed View Article .Korner A , Lauritzen L , Abelskov K , et al .: Ratings scales for depression in the elderly : external and internal validity .", "label": "", "metadata": {}, "score": "62.73487"}
{"text": "These data provide support for the use of citalopram in MDD , at least in the first 8 weeks of treatment .Small study effects were not evident in this review , as there was no marked asymmetry on the visual inspection of the funnel plot .", "label": "", "metadata": {}, "score": "62.76405"}
{"text": "Bech P , Gram LF , Dein E , Jacobsen O , Vitger J , Bolwig TG .Quantitative rating of depressive states .Acta Psychiatr Scand 1975 ; 51 : 161 - 170 .", "label": "", "metadata": {}, "score": "62.821465"}
{"text": "Farahani A , Correll CU .Are antipsychotics or antidepressants needed for psychotic depression ?A systematic review and meta - analysis of trials comparing antidepressant or antipsychotic monotherapy with combination treatment .", "label": "", "metadata": {}, "score": "62.937817"}
{"text": "Conclusion .The reviewed published studies show that citalopram has a statistically significant advantage over placebo with respect to symptom improvement and response rates in adults with MDD .", "label": "", "metadata": {}, "score": "62.97619"}
{"text": "Design A prospective two - phase cohort study .Setting 5 genetic testing centres for AOHD , such as cancer , Huntington 's disease or haemochromatosis , in ambulatory clinics of tertiary hospitals across Canada .", "label": "", "metadata": {}, "score": "62.987724"}
{"text": "To sum up , results of studies on the psychometric performance of the CGI are mixed .Additional research appears necessary .More precisely , the question of whether the CGI provides a valid measure of the patient 's condition and if so whether it is more appropriate to use CGI - I or a difference score of CGI - S as outcome criterion is not ultimately answered .", "label": "", "metadata": {}, "score": "63.049435"}
{"text": "Furthermore - in correspondence with findings from Kadouri et al .[ 18 ] - we expected that this relation improves if not a single clinician does the rating but a whole team of therapists using a consensus process .", "label": "", "metadata": {}, "score": "63.053787"}
{"text": "[PubMed ] .Moran PJ , Mohr DC .The validity of Beck Depression Inventory and Hamilton Rating Scale for Depression items in the assessment of depression among patients with multiple sclerosis .", "label": "", "metadata": {}, "score": "63.20985"}
{"text": "Data collection .I extracted data into an electronic form with sections for each study describing the methods used , study participants , interventions and measured outcomes , as well as sections for bias evaluation .", "label": "", "metadata": {}, "score": "63.267754"}
{"text": "Recently , more empirical evidence for this criticism has been presented .Busner et al .[16 ] found that the CGI ratings of the clinicians are affected by indication - irrelevant adverse events reported by the patient .", "label": "", "metadata": {}, "score": "63.469704"}
{"text": "The Clinical Global Impression Scale ( CGI ) is a brief clinician - rated instrument that consists of three different global measures .Severity of illness : overall assessment of the current severity of the patient 's symptoms ( CGI - S ) ; 2 .", "label": "", "metadata": {}, "score": "63.471695"}
{"text": "San Antonio : The Psychological Corporation Inc ; 1987 .Hamilton M. Development of a rating scale for primary depressive illness .British journal of social and clinical psychology .", "label": "", "metadata": {}, "score": "63.590164"}
{"text": "Significance estimates can not be computed for these two items .Next , invariance analyses were undertaken to compare solutions between CFA models .These analyses indicated that responses did not significantly differ for 4 of 6 items .", "label": "", "metadata": {}, "score": "63.59256"}
{"text": "Concurrent Cognitive - Behavioral ( CBT ) , psychoanalytic , or supportive therapy was not allowed or administered during study period .Patients were forbidden to take any new psychotropic medications during the study .", "label": "", "metadata": {}, "score": "63.620384"}
{"text": "Despite widespread usage , various researchers have questioned whether the HAM - D 17 is a unidimensional or multidimensional instrument [ 12 - 15 ] .", "label": "", "metadata": {}, "score": "63.68761"}
{"text": "Relationship of demographic variables ( gender , age , body weight , height and ethnicity ) , concomitant medications and measures of altered hepatic and renal function were examined by fitting measured CP-601,927 concentrations .", "label": "", "metadata": {}, "score": "63.7287"}
{"text": "Twenty - four patients completed the 8 weeks of the study .Patients ' data are expressed in Table 1 .One patient dropped out after 4 weeks due to obtaining new employment that required relocation and was included in the LOCF analysis .", "label": "", "metadata": {}, "score": "63.8391"}
{"text": "Official Title : .A Randomized Phase 2a , Double - Blind , Placebo - Controlled Study Of The Efficacy And Safety Of CP-601,927 Augmentation Of Antidepressant Therapy In Major Depression .", "label": "", "metadata": {}, "score": "63.897728"}
{"text": "[PubMed ] .Hedges DW , Brown BL , Shwalb DA .A direct comparison of effect sizes from the clinical global impression - improvement scale to effect sizes from other rating scales in controlled trials of adult social anxiety disorder .", "label": "", "metadata": {}, "score": "63.91703"}
{"text": "Reliability and factor analysis .A reliability analysis was performed on 37 items .Twenty items belonging to 18 questions were selected based on the criteria for item selection described in the methods section .", "label": "", "metadata": {}, "score": "63.97559"}
{"text": "The clinical interviews were conducted by clinical psychologists .In the second step , diagnoses were verified through clinical conferences including senior psychotherapists and psychiatrists .", "label": "", "metadata": {}, "score": "63.99037"}
{"text": "406 - 413 , 2012 .View at Google Scholar .J. E. Alpert , G. Papakostas , D. Mischoulon et al . , \" S - adenosyl - L - methionine ( SAMe ) as an adjunct for resistant major depressive disorder : an open trial following partial or nonresponse to selective serotonin reuptake inhibitors or venlafaxine , \" Journal of Clinical Psychopharmacology , vol .", "label": "", "metadata": {}, "score": "64.23303"}
{"text": "[PubMed ] [ Cross Ref ] .Loosman WL , Siegert CE , Korzec A , Honig A. Validity of the Hospital Anxiety and Depression Scale and the Beck Depression Inventory for use in end - stage renal disease patients .", "label": "", "metadata": {}, "score": "64.25261"}
{"text": "PubMed View Article .Bech P , Wilson BP , Wessel T , Junde M , Fava M : A validation analysis of self - reported HAM - D6 versions .", "label": "", "metadata": {}, "score": "64.2886"}
{"text": "Therefore , further work with SAMe is warranted in placebo - controlled , randomized , double - blind clinical trials on larger samples to assess relative benefits and tolerability .", "label": "", "metadata": {}, "score": "64.29348"}
{"text": "This is the first study to develop and validate a psychological screening instrument for the genetic testing field .Strengths and limitations of this study .", "label": "", "metadata": {}, "score": "64.432816"}
{"text": "Efficacy index : overall comparison of the patient 's baseline condition to a ratio of current therapeutic benefit and severity of side effects ( CGI - E ) .", "label": "", "metadata": {}, "score": "64.43291"}
{"text": "PubMed View Article .Callahan EJ , Bertakis KD , Azari R , Robbins JA , Helms LJ , Leigh JP : Association of higher costs with symptoms and diagnosis of depression .", "label": "", "metadata": {}, "score": "64.541046"}
{"text": "Only when these two criteria are met can the scores on the individual items of the scale be added to a clinically and mathematically meaningful total score [ 38 , 39 ] .", "label": "", "metadata": {}, "score": "64.60573"}
{"text": "A couple of different efforts have been made to improve the psychometric characteristics of the CGI .Kadouri et al .[ 18 ] tested the use of a semi - structured interview , a new response format and a Delphi process to improve reliability of the CGI .", "label": "", "metadata": {}, "score": "64.64862"}
{"text": "Further evaluation of citalopram is necessary , incorporating unpublished research .Strengths and limitations of this study .This review is based on a thorough search for published placebo - controlled studies of citalopram for adults with MDD , using a broad search strategy .", "label": "", "metadata": {}, "score": "64.72298"}
{"text": "8396 , p. 224 , 1984 .View at Google Scholar \u00b7 View at Scopus .G. I. Papakostas , C. F. Cassiello , and N. Iovieno , \" Folates and S - adenosylmethionine for major depressive disorder , \" Canadian Journal of Psychiatry , vol .", "label": "", "metadata": {}, "score": "64.78711"}
{"text": "Diagnoses were made by psychiatrists with at least 5-year clinical experience and supervised by senior psychiatrists ( DDB , GM , MDG ) , following the Structured Clinical Interview for DSM - IV ( SCID ) [ 15 ] .", "label": "", "metadata": {}, "score": "64.985115"}
{"text": "The quality of reporting in the reviewed studies is poor , and further evaluation of citalopram , incorporating unpublished research , is necessary to evaluate more definitively its effectiveness in MDD .", "label": "", "metadata": {}, "score": "64.98934"}
{"text": "It is widely accepted and some studies presented evidence arguing that the CGI is a valid assessment instrument .Despite its general acceptance and extensive use as outcome measure and criterion for the validation of other instruments , the CGI 's psychometric characteristics have only rarely been examined so far .", "label": "", "metadata": {}, "score": "65.03431"}
{"text": "Future studies could further address the validity of GPRI in male populations and in the rare AOHDs , such as Huntington 's disease .Introduction .", "label": "", "metadata": {}, "score": "65.09184"}
{"text": "Training procedures .Two graduate research assistants completed a three - day training course in the administration of study measures .After watching a training tape and receiving instructions , they administered study measures in mock interviews until acceptable inter - rater reliability was established vis - \u00e0 - vis semi - structured clinical assessments .", "label": "", "metadata": {}, "score": "65.11513"}
{"text": "5 , pp .638 - 642 , 2011 .View at Publisher \u00b7 View at Google Scholar Abstract .Background .Since its first publication , the Clinical Global Impression Scale ( CGI ) has become one of the most widely used assessment instruments in psychiatry .", "label": "", "metadata": {}, "score": "65.14109"}
{"text": "The GPRI demonstrates promising psychometric properties as a tool designed to help genetics healthcare providers determine which of their patients undergoing genetic testing for AOHD is at increased psychological risk and who will benefit from added psychosocial support .", "label": "", "metadata": {}, "score": "65.25171"}
{"text": "Providers were also asked to suggest additional risk factor items .These suggestions were checked against the literature for empirical evidence .Following this step , seven volunteers undergoing genetic testing for AOHDs were recruited to try out the scale for clarity , succinctness and relevance from the clients ' perspectives .", "label": "", "metadata": {}, "score": "65.41515"}
{"text": "The most commonly reported adverse events were constipation in six patients ( 24 % ) and nausea with decreased appetite in three patients ( 12 % ) .", "label": "", "metadata": {}, "score": "65.50517"}
{"text": "A double - blind , placebo - controlled treatment trial of citalopram for major depressive disorder in older patients with heart failure : the relevance of the placebo effect and psychological symptoms .", "label": "", "metadata": {}, "score": "65.51709"}
{"text": "Primary outcome .Remission of MDD .13 These cut - off points provide a consistent definition of ' remission . 'Secondary outcomes .Secondary outcomes were as follows : ( a ) response of MDD .", "label": "", "metadata": {}, "score": "65.554245"}
{"text": "Chan CH , Janicak PG , Davis JM , Altman E , Andriukaitis S , Hedeker D .Response of psychotic and nonpsychotic depressed patients to tricyclic antidepressants .", "label": "", "metadata": {}, "score": "65.57017"}
{"text": "Subjects : Following informed consent , a convenient sample of 141 participants who had given blood for genetic tests at the Toronto and Ottawa sites completed the GPRI ( using a three patients per item ratio ) to select the best items for the candidate scale .", "label": "", "metadata": {}, "score": "65.73416"}
{"text": "Total possible score is 0 - 24 .CGI - S was defined as 7-point clinician rated scale to assess severity of participant 's current illness state ; range : 1 ( normal - not ill at all ) to 7 ( among the most extremely ill participants ) .", "label": "", "metadata": {}, "score": "65.7926"}
{"text": "Other demographic characteristics of these 63 participants include : most were women and undergoing testing for BRCA1/2 , which was similar to the whole sample of 712 participants ( table 1 ) .", "label": "", "metadata": {}, "score": "65.79679"}
{"text": "This study would have been enhanced if the missing data were available for a more complete analysis , and unpublished studies satisfying inclusion criteria were incorporated into this review .", "label": "", "metadata": {}, "score": "65.824715"}
{"text": "The more such events being reported by the patient , the more likely the clinician rated the patient as more severely ill .The authors concluded that these reports can threaten validity of the CGI seriously .", "label": "", "metadata": {}, "score": "65.84197"}
{"text": "These results support the multidimensional character of the GPRI scale ( see table 3 ) .One additional statement ' I am interested in talking to a counsellor about one or more of these concerns ' was added to the tool at the end as suggested by the participants and providers to remind them of the option of seeing a counsellor if required .", "label": "", "metadata": {}, "score": "65.86464"}
{"text": "At the hospital , patients are treated on an inpatient basis with high - density empirically - based psychotherapy that is personalized depending on the disorder of the patient .", "label": "", "metadata": {}, "score": "65.93973"}
{"text": "Moreover , always in terms of response and remission rates , results of our study are similar to what found in patient with stage I TRD augmented with SAMe .", "label": "", "metadata": {}, "score": "66.002014"}
{"text": "Comparative efficacy and safety of a once - daily dosage of hypericum extract STW3-VI and citalopram in patients with moderate depression : a double - blind , randomised , multicentre , placebo - controlled study .", "label": "", "metadata": {}, "score": "66.12071"}
{"text": "Flagging those individuals who might benefit most from psychosocial care also best utilises the often limited psychological resources in genetic clinics .Our study findings are limited by the characteristics of the sample , in that most participants were women and undergoing testing for BRCA1/2 .", "label": "", "metadata": {}, "score": "66.16467"}
{"text": "In other words , if the dual factors identified by the PCA make sense from a clinical perspective , there is no need to introduce further factors [ 38 ] .", "label": "", "metadata": {}, "score": "66.179855"}
{"text": "A 12-Week Double - Blind , Placebo - Controlled , Flexible - Dose Trial of Pristiq \u00ae ( Desvenlafaxine ) Extended - Release Tablets in Generalized Social Anxiety Disorder .", "label": "", "metadata": {}, "score": "66.203125"}
{"text": "Conclusions Data concerning remission rates for citalopram , relative to placebo , are inconclusive .Response rates and symptom reduction scores in citalopram - treated patients with MDD are significantly better relative to placebo treatment , according to a meta - analysis of published reports .", "label": "", "metadata": {}, "score": "66.278244"}
{"text": "HAM - D 6 + hallucinatory behavior + unusual thought content + suspiciousness + emotional withdrawal + blunted affect .HAMD - BPRS 12 .HAM - D 6 + hallucinatory behavior + unusual thought content + suspiciousness + emotional withdrawal + blunted affect + somatic concern .", "label": "", "metadata": {}, "score": "66.41435"}
{"text": "PubMed View Article .Williams JWJ , Kerber CA , Mulrow CD , Medina A , Aguilar C : Depressive disorders in primary care : prevalence , functional disability , and identification .", "label": "", "metadata": {}, "score": "66.44319"}
{"text": "Such a condition is called treatment - resistant ( or refractory ) depression ( TRD ) and represents a major challenge in everyday \" real world \" clinical practice [ 3 ] .", "label": "", "metadata": {}, "score": "66.481674"}
{"text": "Positive Urine Drug Screen at the Screening visit .Any current unstable and/or clinically significant medical condition , based on history or as evidenced in Screening laboratory and ECG assessments .", "label": "", "metadata": {}, "score": "66.588005"}
{"text": "81 - 87 , 1975 .View at Google Scholar \u00b7 View at Scopus .M. L. Cravo , L. M. Gloria , J. Selhub et al . , \" Hyperhomocysteinemia in chronic alcoholism : correlation with folate , vitamin B-12 , and vitamin B-6 status , \" The American Journal of Clinical Nutrition , vol .", "label": "", "metadata": {}, "score": "66.61568"}
{"text": "Methods .Patients filled in the Beck Depression Inventory ( BDI ) .CGI - S and CGI - I were rated from three perspectives : the treating therapist ( THER ) , the team of therapists involved in the patient 's treatment ( TEAM ) , and the patient ( PAT ) .", "label": "", "metadata": {}, "score": "66.64281"}
{"text": "The full demographic description of the participants is reported in the primary publication on the STOP - PD data [ 31 ] .Question 1 .", "label": "", "metadata": {}, "score": "66.660995"}
{"text": "In our open trial , results support the notion that adjunctive SAMe may be effective in relieving symptomatology of stage II TRD .A statistically significant clinical improvement was reported within the first week of treatment and continued until the end of the study .", "label": "", "metadata": {}, "score": "66.77252"}
{"text": "Similar to phase I , phase II participants were mostly women , at the mid - life stage , and more than half had a past diagnosis of the disease ( see table 1 ) .", "label": "", "metadata": {}, "score": "66.97382"}
{"text": "First , we aimed at clarifying whether the CGI provides a valid measure of the patient 's condition .For this purpose , it was investigated whether CGI ratings correspond to the view the patient has on his or her current condition .", "label": "", "metadata": {}, "score": "66.98682"}
{"text": "Familial context of genetic testing for cancer susceptibility : moderating effect of siblings ' test results on psychological distress one to two weeks after BRCA1 mutation testing .", "label": "", "metadata": {}, "score": "66.99042"}
{"text": "Measures of global psychological functioning and the evolving outcome measurement tools for the genetics field are not designed to ' predict ' vulnerability for future distress , but rather , they measure current distress levels .", "label": "", "metadata": {}, "score": "67.01429"}
{"text": "Further , side effects were generally mild and transient .The most frequently noted effects reported by subjects treated with fluoxetine were nausea , dry mouth , headache , and diarrhea , in decreasing order of frequency .", "label": "", "metadata": {}, "score": "67.02305"}
{"text": "Individuals beginning the genetic testing process for AOHD at each site were approached by genetic counsellors on the project team for their permission to be contacted about the study .", "label": "", "metadata": {}, "score": "67.04749"}
{"text": "In clinical trials clinicians are usually blinded as to what study condition the patient belongs , e.g. , treatment vs. placebo .Thus , they do not know whether it is supportive for the aim of the study to state that the patient improved much or not .", "label": "", "metadata": {}, "score": "67.05493"}
{"text": "Using team consensus , a total of 19 items were removed , combined or substituted , resulting in a 37 item GPRI candidate scale at the end of phase I. .", "label": "", "metadata": {}, "score": "67.10831"}
{"text": "Limitations to this analysis warrant a mention .Most importantly , the original STOP - PD trial was not designed to answer the research questions posed in this study .", "label": "", "metadata": {}, "score": "67.212524"}
{"text": "The GPRI can be completed and scored quickly during clinical visits and without additional burden to patients and health providers .In addition , by focusing specifically on known risk factors associated with inheritable illness , the instrument will be perceived as being more clinically relevant and acceptable to patients .", "label": "", "metadata": {}, "score": "67.36475"}
{"text": "Data from the Study of the Pharmacotherapy of Psychotic Depression ( STOP - PD ) were used for this analysis .As reported elsewhere , STOP - PD is a 12-week , double - blind , randomized trial comparing the remission rates among PD patients treated with either Olanzapine + Placebo or Olanzapine + Sertraline [ 31 ] .", "label": "", "metadata": {}, "score": "67.36996"}
{"text": "Baseline mean MADRS scores were provided in four studies .18 19 22 25 The mean MADRS scores in these studies were above 22 , indicating that patients were moderately ( scores between 22 and 29 ) to severely ( scores of 30 or above ) depressed .", "label": "", "metadata": {}, "score": "67.4578"}
{"text": "Article focus .A significant group of individuals undergoing genetic testing for adult onset disease experience distress or challenges in adaptation , whereas some might develop depression or anxiety .", "label": "", "metadata": {}, "score": "67.475815"}
{"text": "Research assistants approached patients to request their participation in this study .Participation was voluntary and no remuneration was provided .Those who took part provided written consent .", "label": "", "metadata": {}, "score": "67.48636"}
{"text": "Alcohol or substance abuse or dependence .Treatment with a monoamine oxidase inhibitor within 10 weeks of enrollment .Pregnancy or breastfeeding .Clinically significant abnormalities on laboratory tests , electrocardiogram , or physical or neurologic examination .", "label": "", "metadata": {}, "score": "67.52624"}
{"text": "A pan - Canadian practice guideline : screening , assessment and care of psychosocial distress ( depression , anxiety ) in adults with cancer .Psychosomatics 2002 ; 43 : 386 - 93 . . .", "label": "", "metadata": {}, "score": "67.5549"}
{"text": "More recently , new outcome measures designed to assess the psychological impact of receiving genetic information have been developed .For example , the Multidimensional Impact of Cancer Risk Assessment is designed to assess concerns and impacts associated with genetic testing for BRCA1/2 , 19 and another tool , the Psychological Adaptation to Genetic Information Scale , is now available .", "label": "", "metadata": {}, "score": "67.6824"}
{"text": "Limitations .The Study of the Pharmacotherapy of Psychotic Depression ( STOP - PD ) was not designed to answer the research questions posed in this study .", "label": "", "metadata": {}, "score": "67.90924"}
{"text": "Psychol Med .doi : 10.1017/S0033291703007414 .[PubMed ] [ Cross Ref ] .Hiller W , Zaudiga M , Mombour W. ICD International Diagnostic Checklists for ICD-10 and DSM - IV .", "label": "", "metadata": {}, "score": "68.0513"}
{"text": "The GPRI could also be evaluated in primary care settings where genetics services might be offered more frequently to meet the demand .Conclusions .This is the first study to develop a screening tool specifically to help identify individuals undergoing genetic testing for AOHD who are at increased psychological risk .", "label": "", "metadata": {}, "score": "68.10691"}
{"text": "Selection criteria for the literature review included studies with a follow - up design or review articles .Each selected study was reviewed by two reviewers on its quality of evidence and generalisability using a standardised template .", "label": "", "metadata": {}, "score": "68.19629"}
{"text": "Lingjaerde O , Ahlfors UG , Bech P , Dencker SJ , Elgen K .The UKU side effect rating scale .A new comprehensive rating scale for psychotropic drugs and a cross - sectional study of side effects in neuroleptic - treated patients .", "label": "", "metadata": {}, "score": "68.23718"}
{"text": "The Genetic Psychosocial Risk Instrument ( GPRI ) developed in Phase I was tested in Phase II for item refinement and validation .A separate cohort of 722 individuals consented to the study , 712 completed the baseline package and 463 completed all follow - up assessments .", "label": "", "metadata": {}, "score": "68.25632"}
{"text": "Hallucinatory experiences , delusional thought proneness , and psychological distress in a nonclinical population .J Nerv Ment Dis 2007 ; 195 : 484 - 491 .", "label": "", "metadata": {}, "score": "68.37926"}
{"text": "Five studies , with a total of 1541 subjects , were included in the meta - analysis of change from baseline scores ( figure 4 ) .", "label": "", "metadata": {}, "score": "68.40935"}
{"text": "Moreover , chronic depression is a significant risk factor for dementia [ 9 ] .Given that depression is amenable to treatment , valid and reliable screening tools are necessary to identify this patient population .", "label": "", "metadata": {}, "score": "68.48389"}
{"text": "PubMed ] .Montgomery SA , Asberg M. A new depression scale designed to be sensitive to change .British Journal of Psychiatry .doi : 10.1192/bjp.134.4.382 .", "label": "", "metadata": {}, "score": "68.50398"}
{"text": "Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease : the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy ( CREATE ) trial .", "label": "", "metadata": {}, "score": "68.674736"}
{"text": "Each inpatient is treated by only one therapist for as long as eight hours per day .High - density psychotherapy typically includes four phases : ( 1 ) Psychological assessment and a medical examination from which feedback is given to the patient , as is information about the therapy program .", "label": "", "metadata": {}, "score": "68.69331"}
{"text": "All studies , except for Gastpar 2006 , received industry sponsorship .Risk of bias .The risk of bias in included studies is summarised in table 1 .", "label": "", "metadata": {}, "score": "68.694626"}
{"text": "A minimum score of 60 on the LSAS total score at both Screening and Baseline visits .A total HAM - D score of less than 15 at the Screening visit .", "label": "", "metadata": {}, "score": "68.81446"}
{"text": "Kiecolt - Glaser JK , Glaser R : Depression and immune function : central pathways to morbidity and mortality .J Psychosom Res 2002 , 53 : 873 - 876 .", "label": "", "metadata": {}, "score": "68.84321"}
{"text": "The predictive value of a test describes how many of the test - positives ( in this case , a high score on GPRI ) truly have a psychological condition .", "label": "", "metadata": {}, "score": "68.90682"}
{"text": "Saczynski JS , Beiser A , Seshadri S , Auerbach S , Wolf PA , Au R : Depressive symptoms and risk of dementia : The Framingham Heart Study .", "label": "", "metadata": {}, "score": "68.940384"}
{"text": "I inspected the abstracts from the above searches and selected 29 studies for possible inclusion .After examining full text copies of these studies , I compiled a final list of eight studies 18 - 25 that satisfied the inclusion and exclusion criteria .", "label": "", "metadata": {}, "score": "69.04268"}
{"text": "A screening tool designed for genetic testing services is a useful tool to guide clinicians in relation to which patients would benefit from added psychosocial support during the genetic testing process .", "label": "", "metadata": {}, "score": "69.20999"}
{"text": "( 2 ) Cognitive preparation for therapy is given to enhance the patient 's motivation for specific treatment exercises .The patient 's core assumptions about the aetiology of his or her disorder are taken into account when the treatment plan is devised .", "label": "", "metadata": {}, "score": "69.252815"}
{"text": "Conclusions .In summary , in line with previous research [ 16 , 17 , 19 ] the results of the present study cast doubt on the validity of the CGI .", "label": "", "metadata": {}, "score": "69.30128"}
{"text": "Construct validity - correlations : the GPRI was assessed for its correlation with other standardised self - report measures of psychological functioning collected at baseline .", "label": "", "metadata": {}, "score": "69.30582"}
{"text": "Response rates .Overall RR for symptom response with citalopram , relative to placebo , was 1.42 ( 95 % CI 1.17 to 1.73 ) , indicating that the response of MDD in citalopram - treated subjects was 42 % more likely than in those taking placebo .", "label": "", "metadata": {}, "score": "69.39505"}
{"text": "The only criterion available for the validation of the CGI in this study was self - reported data ( BDI and patients ' ratings on CGI ) .", "label": "", "metadata": {}, "score": "69.498825"}
{"text": "The Sheehan Suicidality Tracking Scale ( STS ) measures treatment - emergent suicidal ideation as well as behaviors .It can be administered by a clinician or filled in by a participant .", "label": "", "metadata": {}, "score": "69.51581"}
{"text": "Furthermore , long - term studies are required to demonstrate that patients with stage II TRD can benefit from maintenance treatment with such augmentation and to evaluate long - term tolerability .", "label": "", "metadata": {}, "score": "69.71507"}
{"text": "I applied a random effects model to calculate Hedges ' g for standardised mean differences between citalopram and placebo groups .Standard deviations ( SD ) were computed from the p values , taken at the upper limit and converted into a t - statistic .", "label": "", "metadata": {}, "score": "69.72638"}
{"text": "As already noted , there were no substantial differences between therapists ' and teams ' ratings .One potential explanation is that in our study the therapist who did the single rating was also member of the team of therapists and might have influenced the consensus rating in his favoured direction .", "label": "", "metadata": {}, "score": "69.88077"}
{"text": "4 The perception of control over the disease ( including the number of prevention / treatment options ) and perception of the immediacy of risk ( proximity in age to perceived disease onset ) are important predictors .", "label": "", "metadata": {}, "score": "69.88289"}
{"text": "Maj M , Pirozzi R , Magliano L , Fiorillo A , Bartoli L .Phenomenology and prognostic significance of delusions in major depressive disorder : a 10-year prospective follow - up study .", "label": "", "metadata": {}, "score": "69.96104"}
{"text": "Methods .Scale translation .The HAM - D 6 was first translated from English to Hebrew by a bilingual psychologist , in keeping with accepted procedures [ 29 ] .", "label": "", "metadata": {}, "score": "69.96442"}
{"text": "Descriptive statistics ( means and standard deviations as appropriate ) and percentages were computed for the study sample on demographic variables and all psychometric scales .", "label": "", "metadata": {}, "score": "70.01423"}
{"text": "Social Anxiety Disorder ( SAD ) is recognized as a prevalent , chronic and disabling condition .Lifetime prevalence has been estimated at 13 % in the National Comorbidity Survey .", "label": "", "metadata": {}, "score": "70.04386"}
{"text": "HAM - D 6 + hallucinatory behavior + unusual thought content + suspiciousness .HAMD - BPRS 10 .HAM - D 6 + hallucinatory behavior + unusual thought content + suspiciousness + emotional withdrawal .", "label": "", "metadata": {}, "score": "70.07615"}
{"text": "A principal components factor analysis with varimax rotation was performed on the candidate scale to examine the factor structure and the loading of the items .", "label": "", "metadata": {}, "score": "70.085266"}
{"text": "The aim of this study was to develop a brief , easy - to - use psychosocial screening instrument specific to the genetic testing context and to examine its reliability and validity ( Appendix A ) .", "label": "", "metadata": {}, "score": "70.134895"}
{"text": "All authors read and approved the final manuscript .Funding This study was funded by the Canadian Institutes of Health Research ( CIHR )Grant No .", "label": "", "metadata": {}, "score": "70.148026"}
{"text": "It works with vitamin B12 and vitamin B6 [ 7 ] .Being deficient in either vitamin B12 or vitamin B6 may reduce levels of SAMe in the body leading to the development of depressive symptoms [ 8 , 9 ] .", "label": "", "metadata": {}, "score": "70.15271"}
{"text": "Modified version of figure 4.2 in Bech P. , Clinical Psychometrics , 2012 , Wiley - Blackwell , Chichester , West - Sussex , UK .", "label": "", "metadata": {}, "score": "70.15544"}
{"text": "PubMed View Article .Hu LT , Bentler PM : Cut off criteria for fit indices in covariance structure analysis : conventional criteria versus new alternatives .", "label": "", "metadata": {}, "score": "70.1738"}
{"text": "[ 12 ] found similar effect sizes for MADRS , HAMD and CGI in antidepressant clinical trials which were interpreted by the authors as supporting the CGI 's sensitivity .", "label": "", "metadata": {}, "score": "70.34532"}
{"text": "As a first step , items were required to have at least an 80 % response rate .Second , each item was examined to determine its contribution to the internal consistency of the total 37-item scale .", "label": "", "metadata": {}, "score": "70.35899"}
{"text": "9 , 14 As in other medical areas , specific coping styles can affect adjustment .15 The prior experiences with loss of family members to disease , as well as the developmental level ( ie , young age ) of the individual at the time of the loss , 2 , 3 , 16 are significant factors affecting potential adjustment .", "label": "", "metadata": {}, "score": "70.59047"}
{"text": "The Snaith - Hamilton pleasure scale , \" The British Journal of Psychiatry , vol .167 , pp .99 - 103 , 1995 .", "label": "", "metadata": {}, "score": "70.626144"}
{"text": "To generate items for the Genetic Psychosocial Risk Instrument ( GPRI ) , a literature search was performed for the following AOHDs : Cancer ( Hereditary Breast - Ovarian Cancer Syndrome / Lynch Syndrome ) , Huntington 's disease ( HD ) and haemochromatosis .", "label": "", "metadata": {}, "score": "70.638"}
{"text": "We suggest that future studies further address the validity of GPRI in male populations and in the rare adult onset hereditary diseases , such as HD .", "label": "", "metadata": {}, "score": "70.67055"}
{"text": "Therefore , future studies need to examine the Hebrew HAM - D 6 with larger samples of participants from different age groups derived by random recruitment .", "label": "", "metadata": {}, "score": "70.689865"}
{"text": "To date , the 25 patients included in our study comprise the largest sample of subjects with stage II TRD treated with adjunctive SAMe for an 8-week period .", "label": "", "metadata": {}, "score": "70.76399"}
{"text": "Subjects who started psychotherapy or cognitive - behavioral therapy within 24 weeks of the Baseline visit , except for supportive psychotherapy .Electro - convulsive therapy ( ECT ) within 12 weeks of the Baseline visit .", "label": "", "metadata": {}, "score": "71.1438"}
{"text": "21However , it is too costly and often not feasible in genetic clinics .Standardised measures of psychological functioning ( eg , global scales of depression or anxiety ) can also be used as a method for identifying distress .", "label": "", "metadata": {}, "score": "71.194984"}
{"text": "Included studies were examined for the presence of bias and small study effects .There was no evidence of any significant small study effects .The overall quality of reporting was poor , with insufficient information on the methodology or outcomes .", "label": "", "metadata": {}, "score": "71.424484"}
{"text": "Spitzer R , Endicott J .Schedule for affective disorders and schizophrenia , 3rd edn .New York : Biometrics Research Dept , New York State Psychiatric Institute , 1979 .", "label": "", "metadata": {}, "score": "71.48821"}
{"text": "The total score for the 20-item GPRI ranged from 20 to 100 , with a sample mean of 49.36\u00b113.23 .The total was calculated by the sum of the raw scores for each of the statements .", "label": "", "metadata": {}, "score": "71.63749"}
{"text": "Congruence between patients ' , therapists ' and teams ' perspectives on CGI - S and CGI - I .The effect size for the patient perspective was markedly smaller than for the other two perspectives which coincided with a much bigger standard deviation .", "label": "", "metadata": {}, "score": "71.69365"}
{"text": "The team of therapists concerned with the patient performed a delphi process to reach a consensus rating of the respective patient 's condition .Data analysis .", "label": "", "metadata": {}, "score": "71.72983"}
{"text": "The study was stopped at interim analysis in August 2011 , as stopping criteria for futility were met .There was no statistically significant change on the primary efficacy scale in favor of the drug .", "label": "", "metadata": {}, "score": "71.916855"}
{"text": "It might therefore be possible that clinicians might have been inclined to assign relatively high change scores .However , they also knew that the conducted study did not aim at evaluating therapy effects so that we expect the effect of such demand characteristics in our data to be rather small .", "label": "", "metadata": {}, "score": "71.92518"}
{"text": "Int J Geriatr Psychiatry 2000 ; 15 : 295 - 305 . . .Prospective , multicentre , randomized , double - blind study of the efficacy of escitalopram versus citalopram in outpatient treatment of major depressive disorder .", "label": "", "metadata": {}, "score": "71.94503"}
{"text": "Additionally , effect sizes d between CGI - S dif and CGI - I and their confidence intervals ( 95 % ) were calculated for all three perspectives .", "label": "", "metadata": {}, "score": "71.98315"}
{"text": "30 These two instruments were selected as main outcome measures based on the literature that the standardised interview - based rating scales should be used over subjective report scales as the principal outcome criterion in psychological distress both in general practice and in research trials .", "label": "", "metadata": {}, "score": "72.05261"}
{"text": "Efficacy of SAMe monotherapy in the treatment of MD has been demonstrated in several studies ( for an extensive review , see Papakostas et al .", "label": "", "metadata": {}, "score": "72.057625"}
{"text": "A subgroup of patients undergoing genetic testing required added psychosocial support to facilitate adaptation to genetic / risk information .Busy genetic service providers can face challenges to identify these individuals and provide timely interventions or referrals .", "label": "", "metadata": {}, "score": "72.092354"}
{"text": "Bradfield A , Wells GL .Not the same old hindsight bias : outcome information distorts a broad range of retrospective judgments .Mem Cognit .", "label": "", "metadata": {}, "score": "72.24521"}
{"text": "A cut - off point would need to be determined to guide clinical decisions as to whether or not to refer , further assess or intervene to reduce an individual 's expressed concern .", "label": "", "metadata": {}, "score": "72.25567"}
{"text": "Among various formats ( 17 , 21 , 24 & 28 items ) [ 10 , 11 ] , the 17-item ( HAM - D 17 ) has been used most frequently .", "label": "", "metadata": {}, "score": "72.39273"}
{"text": "Participant characteristics .Study packages were mailed to 1129 individuals interested in hearing more about the study .Of these individuals , 722 of them consented and 712 ( 98 % ) completed the GPRI .", "label": "", "metadata": {}, "score": "72.51671"}
{"text": "We set out to ascertain if the HAM - D 6 measures a unidimensional construct , as proposed by Bech et al .[ 25 ] .", "label": "", "metadata": {}, "score": "72.57294"}
{"text": "The current study aimed at investigating the validity of the CGI - I and CGI - S dif as outcome measures in clinical trials .More precisely , it was examined whether use of CGI - I or CGI - S dif appears more appropriate .", "label": "", "metadata": {}, "score": "72.70591"}
{"text": "[ 12 ] obtained a response rate of 50 % and a remission rate of 43 % following augmentation with SAMe in an open trial on 30 patients partial and non - responders to SSRIs or venlafaxine . than placebo .", "label": "", "metadata": {}, "score": "72.74986"}
{"text": "The SIS also records the number of days impaired by irritability .Change From Double - blind Baseline in Sheehan Disability Scale ( SDS ) Total Score at Weeks 11 and 14 [ Time Frame : Weeks 8 ( double - blind baseline ) , 11 and 14 ] [ Designated as safety issue : No ] .", "label": "", "metadata": {}, "score": "72.75079"}
{"text": "Please refer to this study by its ClinicalTrials.gov identifier : NCT01098240 Still ca n't log in ?Contact the Circulation Department at 1 - 800 - 489 - 1001 x4 or send email .", "label": "", "metadata": {}, "score": "72.88292"}
{"text": "Summary of main results .Two studies provided data on remission rates for citalopram relative to placebo : the difference in remission rates was statistically significant in one study , but not the other .", "label": "", "metadata": {}, "score": "72.93193"}
{"text": "CGI - I responders : defined as having a CGI - I scores of 1 or 2 at Week 12/study endpoint .Clinical Global Impression of Severity Scale ( CGI - S ) [ Time Frame : Baseline to Week 12 ] [ Designated as safety issue : No ] .", "label": "", "metadata": {}, "score": "72.99502"}
{"text": "2 ) Evaluate the safety and tolerability of CP 601,927 in patients with MDD on ADT .Allocation : Randomized Endpoint Classification : Safety / Efficacy Study Intervention Model : Parallel Assignment Masking : Double Blind ( Subject , Investigator )", "label": "", "metadata": {}, "score": "73.004395"}
{"text": "Bech P .Pharmacological treatment of depressive disorders : a review .In : Maj M , Sartorius N , eds .Depressive disorders .WPA series evidence and experience in psychiatry .", "label": "", "metadata": {}, "score": "73.0092"}
{"text": "Methods .Sample .The sample consisted of 31 inpatients of a German psychotherapeutic hospital suffering from a major depressive disorder ( MDD ) according to the criteria of the 10 th edition of the International Classification of Diseases ( ICD-10 ) .", "label": "", "metadata": {}, "score": "73.068245"}
{"text": "Population Pharmacokinetics [ Time Frame : Weeks 11,12 and 14 ] [ Designated as safety issue : No ] .Population pharmacokinetic analysis involved mixed effects modeling using nonlinear mixed effects modeling ( NONMEM ) software .", "label": "", "metadata": {}, "score": "73.13696"}
{"text": "However , according to the classification of Thase and Rush , in the above - mentioned augmentation trials , the majority of the patients belonged to stage I and , to date , efficacy of adjunctive SAMe in stage II TRD has not yet been fully elucidated .", "label": "", "metadata": {}, "score": "73.2841"}
{"text": "Thus , we advocate for the incorporation of multiple self- and clinician - reported scales into the design of clinical trials in addition to CGI in order to gain further insight into CGI 's relation to the patients ' perspective .", "label": "", "metadata": {}, "score": "73.29793"}
{"text": "A high reliability was demonstrated by a Cronbach 's \u03b1 at 0.81 , moderate to high item - total correlation and inter - item correlation of the whole scale .", "label": "", "metadata": {}, "score": "73.44264"}
{"text": "Total Score at Weeks 11 and 14 [ Time Frame : Weeks 8 ( double - blind baseline ) , 11 and 14 ] [ Designated as safety issue : No ] .", "label": "", "metadata": {}, "score": "73.50529"}
{"text": "220 - 224 , 1996 .View at Google Scholar \u00b7 View at Scopus .T. Bottiglieri , M. Laundy , and R. Martin , \" S - adenosylmethionine influences monoamine metabolism , \" The Lancet , vol .", "label": "", "metadata": {}, "score": "73.57367"}
{"text": "View at Google Scholar .J. D. Finkelstein , W. E. Kyle , J. J. Martin , and A. M. Pick , \" Activation of cystathionine synthase by adenosylmethionine and adenosylethionine , \" Biochemical and Biophysical Research Communications , vol .", "label": "", "metadata": {}, "score": "73.61406"}
{"text": "Individuals in advanced stages of the illness or with cognitive impairment or a language barrier were excluded .Interventions Phase I : GPRI items were generated from ( 1 ) a review of the literature , ( 2 ) input from genetic counsellors and ( 3 ) phase I participants .", "label": "", "metadata": {}, "score": "73.614334"}
{"text": "These issues have not been adequately addressed in previous reviews .A re - examination of the role of citalopram in the treatment of MDD is therefore necessary , taking into account the quality of studies , risk of bias and different measures of effectiveness .", "label": "", "metadata": {}, "score": "73.619736"}
{"text": "The four major limitations of our study were the relatively small sample , the open label design , the lack of placebo or active control groups , and the short treatment period ( 8 weeks ) .", "label": "", "metadata": {}, "score": "73.77863"}
{"text": "Publication bias is one potential source of plot asymmetry , not evident here , although this should be more fully assessed after obtaining unpublished research .", "label": "", "metadata": {}, "score": "73.8038"}
{"text": "Studies with a third comparator ( eg , another antidepressant ) were included , if a direct comparison between citalopram and placebo treatments was possible .", "label": "", "metadata": {}, "score": "73.86823"}
{"text": "Agreements and disagreements with other studies or reviews .My estimation of the standardised mean difference for the change from baseline scores is similar to Hedges ' g of 0.31 calculated by Turner on the basis of published studies .", "label": "", "metadata": {}, "score": "74.06079"}
{"text": "PubMed .First MB , Spitzer RI , Gibbon M , Williams JBW : Structured Clinical Interview for DSM - IV Axis I Disorders ( SCID - I ) .", "label": "", "metadata": {}, "score": "74.392334"}
{"text": "In fact , the side - effect profile of SAMe augmentation was very favourable in our study and quite different from other augmentation strategies [ 8 ] .", "label": "", "metadata": {}, "score": "74.41637"}
{"text": "A meta - analysis of response rates was performed to calculate an overall RR of a response to citalopram , compared with placebo , in a random - effects model , using Stata V.9.2 .", "label": "", "metadata": {}, "score": "74.423584"}
{"text": "November 2012 ( final data collection date for primary outcome measure ) .Eligibility Criteria ICMJE .Inclusion Criteria : .Subjects must give written informed consent prior to any study procedures .", "label": "", "metadata": {}, "score": "74.44733"}
{"text": "Nord J Psychiatry 2007 , 61 ( 46 ) : 4 - 80 .PubMed View Article .Landis JR , Koch GG : The measurement of observer agreement for categorical data .", "label": "", "metadata": {}, "score": "74.53339"}
{"text": "The IDCL is a checklist that can be used to make a careful evaluation of the symptoms and classification criteria , and thus help to arrive at precise diagnoses according to ICD-10 criteria for a depressive episode .", "label": "", "metadata": {}, "score": "74.53468"}
{"text": "However , this study and the resulting GPRI represent an attempt to begin the development of a general tool that addresses concerns that are relevant across genetic samples .", "label": "", "metadata": {}, "score": "74.6118"}
{"text": "Clinical global impressions scale .In : ECDEU assessment manual for psychopharmacology .Rockville , MD , USA : US Department of Health , Education and Welfare pub no ( AMD ) 76 - 338 , NIMH , 1976 .", "label": "", "metadata": {}, "score": "74.84736"}
{"text": "The congruence of ratings from the three perspectives on CGI - I was moderate to good and much better than the congruence of ratings on CGI - S. Moreover , while congruence between the single therapists and the teams was moderate to good , patients gave divergent ratings especially on CGI - S dif .", "label": "", "metadata": {}, "score": "74.93965"}
{"text": "Risk factors and psychological impact of genetic testing : the evidence .The knowledge of genetic risk is lifelong and individuals and families often find themselves confronted with an ongoing need to face issues and make decisions .", "label": "", "metadata": {}, "score": "75.18097"}
{"text": "The multistage method 24 takes validation into consideration at each stage of scale development and has been used successfully in previous studies .Phase I : Item generation and refinement .", "label": "", "metadata": {}, "score": "75.2286"}
{"text": "Results of the present study do not suggest a definite recommendation since no strong evidence for the validity of neither CGI - I nor CGI - S dif could be found .", "label": "", "metadata": {}, "score": "75.3044"}
{"text": "Our findings indicate that SAMe augmentation may be effective and well tolerated in stage II TRD .However , limitations of the present study must be considered and further placebo - controlled trials are needed .", "label": "", "metadata": {}, "score": "75.41196"}
{"text": "5 , pp .1183S-1187S , 2002 .View at Google Scholar \u00b7 View at Scopus .S. Clarke and K. Banfield , \" S - adenosylmethionine - dependent methyltransferases , \" in Homocysteine in Health and Disease , R. Carmel and D. Jacobsen , Eds . , pp .", "label": "", "metadata": {}, "score": "75.506165"}
{"text": "Although the onset of an AOHD was not an exclusion criterion , individuals in advanced stages of the illness and/or those who were unable to consent due to cognitive impairment were excluded .", "label": "", "metadata": {}, "score": "75.51758"}
{"text": "The Mokken analysis yielded Loevinger 's coefficients of homogeneity of 0.30 for the HAM - D 17 and 0.50 for the HAM - D 6 respectively .", "label": "", "metadata": {}, "score": "75.55406"}
{"text": "The current study compares both self - report and clinician - rated versions of the Hebrew version of this scale .Methods .A total of 153 Israelis 75 years of age on average participated in this study .", "label": "", "metadata": {}, "score": "75.57431"}
{"text": "Scoring : To ensure that binary items carry an equal weight as the 5-point Likert - type items , a score of 5 was assigned to Yes and 1 to No .", "label": "", "metadata": {}, "score": "75.730995"}
{"text": "Louis and Gabi Weisfeld School of Social Work , Bar - Ilan University .References .Richards D : Prevalence and clinical course of depression : a review .", "label": "", "metadata": {}, "score": "75.86639"}
{"text": "Data was analysed using effect sizes , Spearman 's \u03c1 and intra - class correlations ( ICC ) .Results .Effect sizes between CGI - I and CGI - S dif ratings were large for all three perspectives with substantially higher change scores on CGI - I than on CGI - S dif .", "label": "", "metadata": {}, "score": "75.91792"}
{"text": "Analysis of variance for repeated measures ( ANOVA ) with Bonferroni 's post hoc test was used to evaluate HAM - D scores , whereas Student .", "label": "", "metadata": {}, "score": "75.97644"}
{"text": "Change From Double - blind Baseline in Sheehan Disability Scale ( SDS ) Subscale Score at Weeks 11 and 14 [ Time Frame : Weeks 8 ( double - blind baseline ) , 11 and 14 ] [ Designated as safety issue : Yes ] .", "label": "", "metadata": {}, "score": "76.145004"}
{"text": "Wittchen H - U , Zaudig M , Fydrich T. Strukturiertes Klinisches Interview f\u00fcr DSM - IV .Goettingen , Hogrefe ; 1997 .Hedges LV , Olkin I. Statistical Methods for Meta - Analysis .", "label": "", "metadata": {}, "score": "76.27974"}
{"text": "The CGI - I was rated at discharge only .The third measure is called the efficacy index CGI - E. It was not assessed in the current study [ 1 ] .", "label": "", "metadata": {}, "score": "76.288635"}
{"text": "The IES has two sub - scales : ( 1 ) intrusive thoughts and feelings associated with the stressful life event , and ( 2 ) items associated with patterns of avoidance of certain thoughts , feelings or situations .", "label": "", "metadata": {}, "score": "76.35208"}
{"text": "Reliability analysis was carried out and a Cronbach 's \u03b1 was set for 0.75 or higher for the scale to move to the next phase .", "label": "", "metadata": {}, "score": "76.429504"}
{"text": "Methods .Twenty - five adult outpatients ( 11 males , 14 females ) with a DSM - IV diagnosis of MD were recruited from several mental health facilities in Central Italy and referred to our Institute of Psychiatry .", "label": "", "metadata": {}, "score": "76.78145"}
{"text": "Key messages .Data on remission rates for citalopram in MDD , relative to placebo , are inconclusive .Response rates and symptom improvement scores are significantly better in citalopram - treated patients than in those taking placebo .", "label": "", "metadata": {}, "score": "76.78271"}
{"text": "The Loevinger 's coefficient of homogeneity expresses whether the items of a scale are ordered according to their relationship to the severity of the syndrome being measured , that is , that scorings on lower prevalence items presuppose scorings on higher prevalence items .", "label": "", "metadata": {}, "score": "76.931946"}
{"text": "1081 - 1097 , Raven Press , New York , NY , USA , 1995 .View at Google Scholar . H. Hori and H. Kunugi , \" The efficacy of pramipexole , a dopamine receptor agonist , as an adjunctive treatment in treatment - resistant depression : an open - label trial , \" The Scientific World Journal , vol .", "label": "", "metadata": {}, "score": "77.09304"}
{"text": "Study Arm ( s ) .Experimental : Pristiq .Flexible dose , 50 - 100 mg QD .Intervention : Drug : Pristiq .Placebo Comparator : Placebo .", "label": "", "metadata": {}, "score": "77.26138"}
{"text": "A screening tool , designed for the genetic testing context , would be helpful in assisting geneticists , genetic counsellors or primary care providers to identify this particular group for the implementation of appropriate preventive or follow - up interventions .", "label": "", "metadata": {}, "score": "77.30949"}
{"text": "Conclusions .Results do not suggest a definite recommendation for whether CGI - I or CGI - S dif should be used since no strong evidence for the validity of neither of them could be found .", "label": "", "metadata": {}, "score": "77.39473"}
{"text": "Recent studies comparing St. John 's wort with traditional antidepressant medications have been encouraging , albeit controversial and subject to considerable criticism for questionable methodology and/or study design .", "label": "", "metadata": {}, "score": "77.39661"}
{"text": "This review has been undertaken by a single reviewer .While a single reviewer may be able to select and extract unambiguous data , additional reviewers can help reach consensus regarding areas of ambiguity in published reports .", "label": "", "metadata": {}, "score": "77.44604"}
{"text": "The authors declare that they have no competing interests .Authors ' contributions .TF contributed to conception and design of the study , conducted the statistical analysis and wrote the manuscript .", "label": "", "metadata": {}, "score": "77.46222"}
{"text": "HAMD - BPRS 7 .HAM - D 6 + hallucinatory behavior .HAMD - BPRS 8 .HAM - D 6 + hallucinatory behavior + unusual thought content .", "label": "", "metadata": {}, "score": "77.47315"}
{"text": "Results .The majority of participants were male ( 91/153 or 59.5 % ) .Eighty seven ( 56.9 % ) were currently married and living with a spouse , 54 ( 35.3 % ) were widowed , and 12 ( 8.8 % ) were divorced or lived alone .", "label": "", "metadata": {}, "score": "77.535995"}
{"text": "Intercorrelations between the three perspectives for CGI - I , CGI - S adm , CGI - S dis , and CGI - S dif .", "label": "", "metadata": {}, "score": "77.67954"}
{"text": "Therefore , the final number of participants with complete follow - up data is 463 ( 74 % ) .Owing to the similarity between the dropouts and the completers , we proceeded with reliability and validity analysis of the tool using the subsample that provided outcome data .", "label": "", "metadata": {}, "score": "77.74535"}
{"text": "By contrast , CGI - S only needs representation of the patient 's current condition .If this was the case , in our view , it would threaten the validity of CGI - I as outcome measure in clinical trials .", "label": "", "metadata": {}, "score": "77.97532"}
{"text": "Analysis of the multidimensionality of hallucination - like experiences in clinical and nonclinical Spanish samples and their relation to clinical symptoms : implications for the model of continuity .", "label": "", "metadata": {}, "score": "77.98644"}
{"text": "At the beginning of this phase , the therapist helps the patient to plan and organize the tasks to be undertaken ; thereafter , the patient is asked to independently devise difficult tasks to do .", "label": "", "metadata": {}, "score": "78.09342"}
{"text": "The studies were brief , 2 to 8 weeks in duration , apart from one study , 25 which was 24 weeks in length .The mean age of participants was 42 years , with the age ranging between 18 and 74 years .", "label": "", "metadata": {}, "score": "78.14034"}
{"text": "View at Publisher \u00b7 View at Google Scholar .C. S. Lieber , \" S - adenosyl - L - methionine : Its role in the treatment of liver disorders , \" The American Journal of Clinical Nutrition , vol .", "label": "", "metadata": {}, "score": "78.235985"}
{"text": "Lecrubier Y , Bech P : The Ham D6 is more homogeneous and as sensitive as the Ham D17 .Eur Psychiat 2007 , 22 : 252 - 255 .", "label": "", "metadata": {}, "score": "78.430145"}
{"text": "17 A screening tool enables providers to offer timely and focused educational and psychosocial interventions to prevent future distress .The primary objective of this study was to develop a brief , reliable and valid psychological risk screening instrument for use in the genetic testing context .", "label": "", "metadata": {}, "score": "78.433136"}
{"text": "Method : During a 7-week trial , patients were treated with fluoxetine 20_60 mg or placebo 1_3 capsules per day and were seen in weekly supportive group psychotherapy .", "label": "", "metadata": {}, "score": "78.47483"}
{"text": "We investigated the efficacy of S - Adenosyl - L - Methionine ( SAMe ) augmentation in patients with treatment - resistant depressive disorder ( TRD ) .", "label": "", "metadata": {}, "score": "78.7731"}
{"text": "BMJ Open 2011 ; 1 : e000106 . doi : 10.1136/bmjopen-2011 - 000106 .Funding This study was supported by New South Wales Institute of Psychiatry .", "label": "", "metadata": {}, "score": "78.87398"}
{"text": "Average tolerability scores were also better for patients taking St. John 's wort extract , and these patients had fewer adverse reactions compared to those treated with imipramine .", "label": "", "metadata": {}, "score": "78.92933"}
{"text": "PubMed ] [ Cross Ref ] .J Psychiatr Res .doi : 10.1016/j.jpsychires.2010.03.006 .[PubMed ] [ Cross Ref ] .Korner A , Lauritzen L , Abelskov K , Gulmann NC , Brodersen AM , Wedervang - Jensen T , Marie Kjeeldgaard K. Rating scales for depression in the elderly : external and internal validity .", "label": "", "metadata": {}, "score": "79.322586"}
{"text": "All authors read and approved the final manuscript .Pre - publication history .References .Guy W. ECDEU Assessment Manual for Psychopharmacology .Rockville , MD : U.S. Department of Health , Education , and Welfare ; 1976 .", "label": "", "metadata": {}, "score": "79.57234"}
{"text": "Cohen J. Statistical power for the behavioural science .Hillsdale , NJ : Erlbaum ; 1988 .McGraw KO , Wong SP .Forming inferences about some intraclass correlation coefficients .", "label": "", "metadata": {}, "score": "79.67203"}
{"text": "Measures .The Structured Clinical Interview for DSM - IV ( SCID - I ) .The SCID - I is a semi - structured interview to assist clinicians in making a DSM - IV Axis I diagnosis [ 31 ] .", "label": "", "metadata": {}, "score": "79.70211"}
{"text": "PubMed View Article .Koller M , Aaronson NK , Blazeby J , et al .: Translation procedures for standardized quality of life questionnaires : The European Organization for Research and Treatment of Cancer ( EORTC ) approach .", "label": "", "metadata": {}, "score": "79.815735"}
{"text": "Not Provided .Original Other Outcome Measures ICMJE .Not Provided .Descriptive Information .Brief Title ICMJE .12-Week Study of Pristiq ( Desvenlafaxine ) Social Anxiety Disorder .", "label": "", "metadata": {}, "score": "80.049934"}
{"text": "The ROC curve for the GPRI was 0.78 , which is considered as an indicator of an adequate screening instrument .An important purpose of the GPRI in our study was to identify individuals at risk for postgenetic testing psychological distress .", "label": "", "metadata": {}, "score": "80.09903"}
{"text": "YGB wrote the manuscript and made critical revisions .LA , MG and PB conceived , developed and designed the study .LA also supervised the data collection .", "label": "", "metadata": {}, "score": "80.115906"}
{"text": "Despite the benefits of genetic testing , such as increased screening or prophylactic interventions , individuals at high risk for serious illness may become increasingly fearful or distressed about the future .", "label": "", "metadata": {}, "score": "80.13092"}
{"text": "The results of the present study showed that CGI - I provided relatively high change scores compared to the difference score CGI - S dif in terms of effect sizes .", "label": "", "metadata": {}, "score": "80.26117"}
{"text": "Items are rated on a scale of 0 - 10 visual analog scale , for a total numeric range of scores from 0 ( not at all impaired ) to 30 ( extremely impaired ) .", "label": "", "metadata": {}, "score": "80.27244"}
{"text": "Fluoxetine within 28 days of Baseline .MAO inhibitors within 14 days of Baseline - Any other psychotropics ( including SSRIs , SNRIs , and benzodiazepines ) within 14 days of Baseline .", "label": "", "metadata": {}, "score": "80.73585"}
{"text": "MB participated in the design of the study and the statistical analysis .RJ and MP participated in the design of the study and coordinated the data acquisition .", "label": "", "metadata": {}, "score": "80.85078"}
{"text": "Question 1 .This method is opposed to the ' American ' approach , which identifies several factors by means of ' orthogonal ' or ' oblique ' rotation [ 38 ] .", "label": "", "metadata": {}, "score": "80.94783"}
{"text": "In order to reduce sampling error effect sizes have been corrected using a factor provided by Hedges and Olkin [ 23 ] .Before calculating effect sizes , CGI - S dif was rescaled for this step of analysis into values from 1 to 7 with 4 meaning no change in order to bring CGI - I and CGI - S dif to a common metric .", "label": "", "metadata": {}, "score": "80.97868"}
{"text": "Because interval scale level of data collected with the CGI could not be taken for granted we decided to report both measures for interval scale level data and measures for ordinal scale level data .", "label": "", "metadata": {}, "score": "81.01355"}
{"text": "After discharge , therapists remain in telephone contact with their patients for at least six weeks .Material .Beck Depression Inventory ( BDI ) .", "label": "", "metadata": {}, "score": "81.14984"}
{"text": "Female subjects of childbearing potential must commit to an effective form of contraception for the duration of the trial .Effective forms of contraception include : condoms with spermicide , diaphragm with spermicide , hormonal contraceptive agents ( oral , transdermal , or injectable ) , and implantable contraceptive devices .", "label": "", "metadata": {}, "score": "81.53292"}
{"text": "[ 18 ] a consensus rating following a Delphi process does not necessarily change reliability or validity of the rating .A couple of limitations of the current study have to be reported .", "label": "", "metadata": {}, "score": "81.76546"}
{"text": "The GPRI has the potential to be used as a clinical screening tool and as a validated measure for future studies .Acknowledgments .The first author is a recipient of a career scientist award from the Canadian Institutes of Health Research ( CIHR ) and the Ontario Women 's Health Council .", "label": "", "metadata": {}, "score": "81.77081"}
{"text": "Int Clin Psychopharmacol .doi : 10.1097/00004850 - 200211000 - 00003 .[PubMed ] [ Cross Ref ] .Beneke M , Rasmus W. \" Clinical Global Impressions \" ( ECDEU ) : some critical comments .", "label": "", "metadata": {}, "score": "82.306076"}
{"text": "Major depressive disorder ( MD ) is a severe , highly prevalent illness that has a substantial impact on public health and human functioning worldwide [ 1 ] .", "label": "", "metadata": {}, "score": "82.339806"}
{"text": "A double - blind , placebo - controlled study of citalopram with and without lithium in the treatment of therapy - resistant depressive patients : a clinical , pharmacokinetic , and pharmacogenetic investigation .", "label": "", "metadata": {}, "score": "82.39708"}
{"text": "[ 30 ] criteria that is conducted by a clinical expert .Thus , future studies should incorporate interview - based assessments at discharge for replication of the present findings .", "label": "", "metadata": {}, "score": "82.53495"}
{"text": "Interventional .Study Phase .Phase 4 .Study Design ICMJE .Allocation : Randomized Endpoint Classification : Safety / Efficacy Study Intervention Model : Parallel Assignment Masking : Double Blind ( Subject , Investigator , Outcomes Assessor ) Primary Purpose : Treatment .", "label": "", "metadata": {}, "score": "82.81461"}
{"text": "All statistical tests were two - tailed , and statistical significance was declared at the 0.05 \u03b1 level .All results are presented as mean \u00b1 standard deviation ( SD ) .", "label": "", "metadata": {}, "score": "82.936554"}
{"text": "Current Secondary Outcome Measures ICMJE ( submitted : October 6 , 2014 ) .Clinical Global Impression of Improvement Scale ( CGI - I ) [ Time Frame : Baseline to Week 12 ] [ Designated as safety issue : No ] .", "label": "", "metadata": {}, "score": "82.94086"}
{"text": "Intervention : Drug : Placebo .Not Provided .Recruitment Information .Recruitment Status ICMJE .Completed .Enrollment ICMJE .Completion Date .December 2012 .", "label": "", "metadata": {}, "score": "82.98688"}
{"text": "Change From Double - blind Baseline in Bech Melancholia Subscale Score at Weeks 9 Through 14 [ Time Frame : Weeks 8 ( double - blind baseline ) through 14 ] [ Designated as safety issue : No ] .", "label": "", "metadata": {}, "score": "83.17807"}
{"text": "Hum Psychopharmacol .doi : 10.1002/hup.966 .[PubMed ] [ Cross Ref ] .Zaider TI , Heimberg RG , Fresco DM , Schneier FR , Liebowitz MR .", "label": "", "metadata": {}, "score": "83.1984"}
{"text": "Search methods .I carried out an electronic search of the Cochrane Central Register of Controlled Trials , Medline ( from 1950 ) , PsychINFO ( from 1967 ) and EMBASE ( from 1980 ) up to February 2011 .", "label": "", "metadata": {}, "score": "83.24657"}
{"text": "Based on Guy 's [ 15 ] notion on the role of memory when using CGI - I we expected that difference scores for CGI - S were the more valid measure .", "label": "", "metadata": {}, "score": "83.43335"}
{"text": "PubMed ] [ Cross Ref ] .Jiang Q , Ahmed S. An analysis of correlations among four outcome scales employed in clinical trials of patients with major depressive disorder .", "label": "", "metadata": {}, "score": "83.45857"}
{"text": "A search of the Cochrane Central Register of Controlled Trials using the above search terms produced 31 unique articles , Medline 244 , PsychINFO 60 and EMBASE 202 , giving a total of 537 articles , after removing duplicates .", "label": "", "metadata": {}, "score": "83.688644"}
{"text": "A.J. Flint has received grant support from the NIMH , the Canadian Institutes of Health Research , and Lundbeck and has received honoraria from Janssen - Ortho , Lundbeck Canada , and Pfizer Canada .", "label": "", "metadata": {}, "score": "83.73534"}
{"text": "He is receiving medication donated by Pfizer and Eli Lilly for his NIMH trial .During the last three years , he has provided legal consultation to AstraZeneca and research consultation for Forest Laboratories .", "label": "", "metadata": {}, "score": "83.93198"}
{"text": "21 Distress may not become manifest to the healthcare team until the patient reaches an observable crisis level , that is , the onset of severe depression or anxiety , or in case of significant conflicts with the family .", "label": "", "metadata": {}, "score": "84.045654"}
{"text": "CGI - I was defined as a 7-point clinician rated scale ranging from 1 ( very much improved ) to 7 ( very much worse ) .", "label": "", "metadata": {}, "score": "84.29679"}
{"text": "This study is designed to evaluate the efficacy and safety of Pristiq \u00ae in treatment of the symptoms of Generalized Social Anxiety Disorder ( SAD ) .", "label": "", "metadata": {}, "score": "84.40926"}
{"text": "The CGI - S was rated at admission ( CGI - S adm ) and at discharge ( CGI - S dis ) .The CGI global improvement measure ( CGI - I ) is rated from 1 ( very much improved ) to 7 ( very much worse ) .", "label": "", "metadata": {}, "score": "84.62555"}
{"text": "Our results do not suggest a definite recommendation for whether CGI - I or CGI - S dif should be used since no strong evidence for the validity of neither CGI - I nor CGI - S dif in terms of high correlations with ratings from the patients ' perspective could be found .", "label": "", "metadata": {}, "score": "84.74436"}
{"text": "doi : 10.1007/s10865 - 005 - 2561 - 0 .[PubMed ] [ Cross Ref ] .American Psychological Association .Diagnostic and statistical manual of mental disorders , fourth edition .", "label": "", "metadata": {}, "score": "84.94392"}
{"text": "doi : 10.1055/s-2007 - 1014401 .[PubMed ] [ Cross Ref ] .Dahlke F , Lohaus A , Gutzmann H. Reliability and clinical concepts underlying global judgments in dementia : implications for clinical research .", "label": "", "metadata": {}, "score": "85.07585"}
{"text": "Effect sizes between CGI - I and CGI - S dif ratings were large for all three perspectives ( see figure \u200b figure1 ) 1 ) with substantially higher change scores on CGI - I than on CGI - S dif .", "label": "", "metadata": {}, "score": "85.263855"}
{"text": "He directly own stocks of General Electric ( less than $ 5,000 ) .Within the past three years , he has also received some travel support from Roche .", "label": "", "metadata": {}, "score": "85.43675"}
{"text": "Shalev A , Sahar T , Abramovitz M : Structured Clinical Interview for DSM - IV Axis I Disorders ( SCID - I ) .Department of Psychiatry : Hadassah University Hospital , Jerusalem , Israel ; 1996 .", "label": "", "metadata": {}, "score": "85.51177"}
{"text": "An Axis I disorder other than SAD ( e.g. , post - traumatic stress disorder , obsessive compulsive disorder , panic disorder ) within 24 weeks of the Baseline visit .", "label": "", "metadata": {}, "score": "85.55147"}
{"text": "Gender .Both .Ages .18 Years to 75 Years .Accepts Healthy Volunteers .No .Contacts ICMJE .Contact information is only displayed when the study is recruiting subjects Abstract .", "label": "", "metadata": {}, "score": "86.51341"}
{"text": "Citalopram is a selective serotonin - reuptake inhibitor antidepressant , commonly used in the treatment of major depressive disorder ( MDD ) .It is often recommended as a first - line treatment for this condition .", "label": "", "metadata": {}, "score": "86.58734"}
{"text": "The degree to which irritability interferes with work , social and family function is also queried .The total SIS score is the sum of 7 items .", "label": "", "metadata": {}, "score": "86.7697"}
{"text": "Limitations .This systematic review is limited to published studies .Its results are subject to a review of unpublished research and outcome data that are missing from published reports .", "label": "", "metadata": {}, "score": "86.7811"}
{"text": "44 45 The study by Montgomery et al 46 was excluded , as the data in this study were reported in a larger trial by Lepola et al .", "label": "", "metadata": {}, "score": "87.05812"}
{"text": "Correlations with BDI dif thus differed between perspectives but not between CGI - I and CGI - S dif .Effect sizes between CGI - I and CGI - S dif for the perspectives patient ( PAT ) , therapist ( THER ) and team of therapists concerned with the patient ( TEAM ) .", "label": "", "metadata": {}, "score": "87.20302"}
{"text": "Although the difference appears minimal , it might have had an effect on the results .The corresponding Hebrew wording translates to : \" I have felt clearly slowed down or passive and have been talking much less than usual , \" and \" I have hardly been talking at all and feel extremely slowed down all the time .", "label": "", "metadata": {}, "score": "87.29004"}
{"text": "The informed consent included all components of the study , including questionnaires , follow - up phone calls , telephone interviews , as well as the release of their genetic testing information to the research team .", "label": "", "metadata": {}, "score": "87.92334"}
{"text": "Databases including Cinahl ( 1982 - 2006 ) , Medline ( 1966 - 2006 ) , PsychInfo ( 1985 - 2006 ) and Pubmed ( 1985 - 2006 ) were searched , apet from a hand search of references from major publications .", "label": "", "metadata": {}, "score": "88.67627"}
{"text": "All participants took part voluntarily without payment and signed an informed consent prior to testing .The study procedures were in accordance with the declaration of Helsinki and approved by the local ethics committee of the Medical Faculty of the RWTH Aachen University ( EK 172/05 ) .", "label": "", "metadata": {}, "score": "88.79833"}
{"text": "Inclusion criteria were : 60 + years of age , fluent in Hebrew , and no pronounced cognitive loss ( determined using a 6-item screening measure [ 30 ] ) .", "label": "", "metadata": {}, "score": "89.54395"}
{"text": "Park MH , Kim TS , Yim HW et al .Clinical characteristics of depressed patients with a history of suicide attempts : results from the CRESCEND study in South Korea .", "label": "", "metadata": {}, "score": "89.5692"}
{"text": "The second principal component was bidirectional with an eigenvalue of 1.64 .The distribution of the negative vs. positive loadings for this bidirectional factor is also shown in Table 1 .", "label": "", "metadata": {}, "score": "89.60432"}
{"text": "Grant No .AHC 73144 .We would like to express our gratitude to all the genetic testing patients who participated in our study .Thank you for your contribution towards this very important work and the development of the instrument .", "label": "", "metadata": {}, "score": "89.75034"}
{"text": "The analysis of responsiveness was based on the last observation carried forward method , and all correlations were made using the SAS statistical package ( version 9.00 , 2002 ) .", "label": "", "metadata": {}, "score": "90.07079"}
{"text": "Escitalopram versus nortriptyline : how to let the clinical GENDEP data tell us what they contained .Acta Psychiatr Scand 2013 ; 127 : 328 - 329 .", "label": "", "metadata": {}, "score": "90.19817"}
{"text": "Lancet 2007 , 370 : 851 - 858 .PubMed View Article .Murray CJ , Lopez AD : Global mortality , disability , and the contribution of risk factors : Global Burden of Disease Study .", "label": "", "metadata": {}, "score": "90.25618"}
{"text": "Conflict of Interests .The authors have no conflict of interests with any commercial or other associations in connection with the submitted paper .References .", "label": "", "metadata": {}, "score": "90.55179"}
{"text": "One of clinical strategies in TRD is to add a second agent with recognized or reputed antidepressant properties [ 1 , 5 ] .S - Adenosyl - Methionine ( commonly known as SAMe ) is a naturally occurring molecule distributed in virtually all body tissues and fluids and is involved in many important processes [ 6 ] .", "label": "", "metadata": {}, "score": "91.007614"}
{"text": "Talk with your doctor and family members or friends about deciding to join a study .To learn more about this study , you or your doctor may contact the study research staff using the Contacts provided below .", "label": "", "metadata": {}, "score": "91.62866"}
{"text": "Effexor XR , which is mechanistically similar to Pristiq \u00ae , was found effective for subjects with Generalized Social Anxiety Disorder in all five of the placebo controlled trials in which it was studied .", "label": "", "metadata": {}, "score": "92.42023"}
{"text": "Competing interests None .Ethics approval Research Ethics Board approval was obtained at all five participating sites : Toronto ( Mount Sinai Hospital , North York General Hospital , Princess Margaret Hospital ) ; Ottawa ( Children 's Hospital of Eastern Ontario ) ; and Vancouver ( British Columbia Cancer Agency ) .", "label": "", "metadata": {}, "score": "92.507706"}
{"text": "[PubMed ] .Guy W. In : Handbook of Psychiatric Measures .Rush AJ , editor .Washington , DC : American Psychiatric Association ; 2000 .", "label": "", "metadata": {}, "score": "92.74245"}
{"text": "Participants were recruited in the waiting rooms of two primary care clinics operated by Clalit Health Services ( Israel 's largest health insurance provided serving 53 % of the population ) .", "label": "", "metadata": {}, "score": "92.918564"}
{"text": "The Hebrew version of the SCID - I was translated and validated by Shalev et al .[ 32 ] .All study participants were interviewed using this instrument .", "label": "", "metadata": {}, "score": "93.09883"}
{"text": "Bech P , Fava M , Trivedi MH , Wisniewski SR , Rush AJ .Acta Psychiatr Scand 2012 ; 125 : 342 - 348 .", "label": "", "metadata": {}, "score": "93.6662"}
{"text": "All authors have read and approved the final manuscript .Authors ' Affiliations .Department of Public Health and the Center for Multidisciplinary Research in Aging , Faculty of Health Sciences , Ben - Gurion University of the Negev .", "label": "", "metadata": {}, "score": "93.67543"}
{"text": "Ann Gen Psychiatry .doi : 10.1186/1744 - 859X-9 - 35 .[ PMC free article ] [ PubMed ] [ Cross Ref ] .Beck AT , Steer RA .", "label": "", "metadata": {}, "score": "94.00383"}
{"text": "Declarations .Acknowledgments .This study has been made possible by a research grant from Lundbek International .Competing interests .The authors declare that they have no competing interests .", "label": "", "metadata": {}, "score": "94.61873"}
{"text": "Washington DC ; 1994 .World Health Organization .The ICD-10 classification of mental and behavioral disorders : clinical descriptions and diagnostic guidelines .Geneva ; 1992 .", "label": "", "metadata": {}, "score": "95.290054"}
{"text": "Means and standard deviations ( SD ) for CGI - S adm , CGI - S dis and for CGI - I were calculated .Corrected effect sizes d were calculated between CGI - S adm and CGI - S dis for all three perspectives .", "label": "", "metadata": {}, "score": "95.57507"}
{"text": "In fact , there is now a general consensus that genetic testing should be accompanied by psychological support to promote optimal adjustment .Screening for psychological risk factors : why is it necessary ?", "label": "", "metadata": {}, "score": "95.5785"}
{"text": "Contributors Dr MJE was the PI and lead writer , who conceived the idea of the study .Dr MC was the co - principal investigator who co - led the study .", "label": "", "metadata": {}, "score": "96.11692"}
{"text": "Danish University Antidepressant Group .Citalopram : clinical effect profile in comparison with clomipramine .A controlled multicenter study .Danish University Antidepressant Group .Psychopharmacology ( Berl ) 1986 ; 90 : 131 - 8 . . .", "label": "", "metadata": {}, "score": "96.421585"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .W. Guy and Clinical Global Impression , ECDEU Assessment Manual for Psychopharmacology , National Institute of Mental Health , Rockville , Md , USA , 1976 .", "label": "", "metadata": {}, "score": "96.974014"}
{"text": "The brief psychiatric rating scale .Psychol Rep 1962 ; 10 : 799 - 812 .Received 15 March 2013 ; Accepted 18 April 2013 .", "label": "", "metadata": {}, "score": "97.02024"}
{"text": "In English , the second response option for the social interaction and interests item reads : \" I have felt that I have had difficulty performing my daily activities , but I was still able to perform them with great effort .", "label": "", "metadata": {}, "score": "98.184296"}
{"text": "Community Division , Clalit Health Services , Tel Aviv , Israel and Department of Family , Health Care , Bruce Rappaport Faculty of Medicine , The Technion .", "label": "", "metadata": {}, "score": "98.50616"}
{"text": "doi : 10.1002/hup.989 .[PubMed ] [ Cross Ref ] .Khan A , Khan SR , Shankles EB , Polissar NL .", "label": "", "metadata": {}, "score": "99.26016"}
{"text": "Depress Anxiety 2006 ; 23 : 441 - 8 .St. John 's Wort Shown Effective as Antidepressant .The ancient Greeks were among the first to advocate the use of Hypericum perforatum ( St. John 's wort ) as a treatment against \" demonic possession . \"", "label": "", "metadata": {}, "score": "99.28873"}
{"text": "Int Clin Psychopharmacol .doi : 10.1097/YIC.0b013e32833a86aa .[PubMed ] [ Cross Ref ] .Hsieh MH , Lin WW , Chen ST , Chen KC , Chen KP , Chiu NY , Huang C , Chang CJ , Lin CH , Lai TJ .", "label": "", "metadata": {}, "score": "100.08081"}
{"text": "Declaration of interest .S.D. \u00d8stergaard has received speaking fees , consultant honoraria , and travel support from Janssen - Cilag until April 2011 .Furthermore , he has received travel support at one occasion in 2010 from Bristol - Myers Squibb .", "label": "", "metadata": {}, "score": "100.32453"}
{"text": "Correction notice The \" To cite : ... \" information and running footer in this article have been updated with the correct volume number ( volume 1 ) .", "label": "", "metadata": {}, "score": "100.39583"}
{"text": "doi : 10.1186/1471 - 244X-7 - 7 .[ PMC free article ] [ PubMed ] [ Cross Ref ] .Targum SD , Busner J , Young AH .", "label": "", "metadata": {}, "score": "101.04603"}
{"text": "6 , pp .661 - 664 , 2004 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .167 , no . 8 , pp .", "label": "", "metadata": {}, "score": "103.94115"}
{"text": "PubMed View Article .American Psychiatric Association : Diagnostic and Statistical Manual of Mental Disorders .Washington , DC : Revised 4th ed ; 2000 .", "label": "", "metadata": {}, "score": "105.573685"}
{"text": "Finally , the team would like to pay special recognition to the late Dr Anne Summers , who was the coinvestigator on the team .Her dedication to the need for empirically based tools and her strong vision to support recipients of new genetic technology were key influences in the conceptualisation , funding and completion of this study .", "label": "", "metadata": {}, "score": "107.08579"}
{"text": "Eli Lilly donated olanzapine and Pfizer donated sertraline and placebo / sertraline for the STOP - PD .Neither Eli Lilly nor Pfizer participated in the design , implementation , collection , analysis , or interpretation of data in the STOP - PD or in the preparation , review , or approval of this manuscript .", "label": "", "metadata": {}, "score": "108.164276"}
{"text": "doi : 10.4088/JCP.v68n0305 .[PubMed ] [ Cross Ref ] .Lindenmayer JP , Czobor P , Alphs L , Nathan AM , Anand R , Islam Z , Chou JC .", "label": "", "metadata": {}, "score": "108.52001"}
{"text": "289 , no .23 , pp .3095 - 3105 , 2003 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "108.6368"}
{"text": "View Article .Pre - publication history .Copyright .\u00a9 Bachner et al . ; licensee BioMed Central Ltd. 2013 .This article is published under license to BioMed Central Ltd.", "label": "", "metadata": {}, "score": "115.83996"}
{"text": "View at Publisher \u00b7 View at Google Scholar .163 , no . 7 , pp .1161 - 1172 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "129.84645"}
{"text": "Copyright \u00a9 2013 Domenico De Berardis et al .This is an open access article distributed under the Creative Commons Attribution License , which permits unrestricted use , distribution , and reproduction in any medium , provided the original work is properly cited .", "label": "", "metadata": {}, "score": "141.99329"}
{"text": "Acknowledgements .They did not participate in the collection , analysis , or interpretation of study data or in the preparation , review , or approval of this manuscript .", "label": "", "metadata": {}, "score": "142.17894"}
